"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value";"Value"
"CHEMBL2036870";"";"None";"317.35";"0";"3.48";"2h";"Cn1c(-c2ccnc(Nc3cccc(O)c3)n2)nc2ccccc21";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"16.57";"0.30";"1.78";"6.93";"0";"CHEMBL2038023";"Inhibition of recombinant Aurora B using tetra(LRRWSLG) as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2185";"Serine/threonine-protein kinase Aurora-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034932";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";"";"5.5"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"14.9";"nM";"7.83";"";"";"UO_0000065";"12.72";"0.29";"3.89";"7.31";"0";"CHEMBL4433501";"Inhibition of MEK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4433204";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"14.9"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909187";"DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF)";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"Platelet";"None";"";"";"";"CHEMBL250";"Platelet activating factor receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833781";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909188";"DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"NIH3T3";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307716";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909174";"DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2035";"Muscarinic acetylcholine receptor M5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909201";"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)";"B";"BAO_0000357";"single protein format";"Escherichia coli";"None";"None";"None";"None";"";"";"";"CHEMBL260";"MAP kinase p38 alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909209";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL273";"Serotonin 1a (5-HT1a) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909106";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL210370";"";"None";"646.93";"3";"5.62";"6d";"N=C(NCCCNCCCCNCCCNC(=N)NCC(c1ccccc1)c1ccccc1)NCC(c1ccccc1)c1ccccc1";"IC50";"'='";"4560.0";"nM";"5.34";"";"";"UO_0000065";"8.26";"0.15";"-0.28";"4.46";"0";"CHEMBL869331";"Inhibition of Trypanosoma cruzi TR";"B";"BAO_0000357";"single protein format";"Trypanosoma cruzi";"None";"None";"None";"None";"";"";"";"CHEMBL5131";"Trypanothione reductase";"Trypanosoma cruzi";"SINGLE PROTEIN";"CHEMBL1148496";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";"";"4.56"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"4";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL4403344";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402527";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"4.0"
"CHEMBL2011870";"";"None";"302.40";"0";"3.72";"14";"COc1ccc(-c2nsc(NC(=O)[C@@H]3C[C@H]3C)c2C)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2016180";"Allosteric antagonist activity at human recombinant mGluR1 expressed in AV12 cells assessed as intracellular calcium concentration using Fluo-3 dye by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"AV12";"None";"";"";"";"CHEMBL3772";"Metabotropic glutamate receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"9.0"
"CHEMBL2011870";"";"None";"302.40";"0";"3.72";"14";"COc1ccc(-c2nsc(NC(=O)[C@@H]3C[C@H]3C)c2C)cc1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2016182";"Antagonist activity at rat mGluR1";"F";"BAO_0000019";"assay format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL4477";"Metabotropic glutamate receptor 1";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL2010791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"0.9"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909117";"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"U-937";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308006";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909202";"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)";"B";"BAO_0000357";"single protein format";"Escherichia coli";"None";"None";"None";"None";"";"";"";"CHEMBL4445";"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909205";"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Insect cells";"None";"";"";"";"CHEMBL1824";"Receptor protein-tyrosine kinase erbB-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2013170";"";"None";"445.50";"0";"3.23";"32";"NCNC(=O)c1cncc(-c2cnc(Nc3cc(N4CCC(F)(F)CC4)ccn3)s2)c1";"IC50";"'='";"317.0";"nM";"6.50";"";"";"UO_0000065";"14.59";"0.29";"3.27";"5.96";"0";"CHEMBL2014580";"Inhibition of CDK7";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3055";"Cyclin-dependent kinase 7";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010672";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"317.0"
"CHEMBL2103872";"CEFTOLOZANE";"4.0";"666.70";"3";"-3.90";"CXA-101, FR-264205";"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1";"IC50";"'='";"0.02";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1658202";"Inhibition of Pseudomonas aeruginosa PAO1 PBP3 by SDS-PAGE";"B";"BAO_0000019";"assay format";"Pseudomonas aeruginosa PAO1";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1649308";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"None";"";"";"";"0.02"
"CHEMBL2103831";"NAPROXCINOD";"3.0";"347.37";"0";"3.48";"Naproxcinod";"COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1";"IC50";"'='";"5248.07";"nM";"5.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880993";"Vasorelaxing effect in Wistar rat thoracic aorta ring assessed as reduction of KCl-induced contractile tone";"F";"BAO_0000019";"assay format";"Rattus norvegicus";"CHEMBL3638215";"Thoracic aorta";"None";"None";"";"";"";"CHEMBL612546";"Molecular identity unknown";"";"UNKNOWN";"CHEMBL3880420";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"None";"";"";"";"5.28"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"16.24";"0.30";"4.04";"6.21";"0";"CHEMBL4771396";"Inhibition of human HDAC7 expressed in baculovirus infected sf9 cells using (Boc-Lys(trifluoroacetyl)-AMC) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2716";"Histone deacetylase 7";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"350.0"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"16.53";"0.32";"4.10";"9.75";"0";"CHEMBL3992007";"Inhibition of PDGFRalpha V561D mutant (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"P16234";"V561D";"CHEMBL2007";"Platelet-derived growth factor receptor alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"None";"";"";"";"0.04"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"5140.0";"nM";"5.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992020";"Cytotoxic activity in human DMS153 cells expressing Rad51";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DMS-153";"None";"";"";"";"CHEMBL2366167";"DMS-153";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3308260";"";"";"";"5.14"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"1";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5227182";"Anticancer activity against human HCC70 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCC70";"None";"";"";"";"CHEMBL1075461";"HCC70";"Homo sapiens";"CELL-LINE";"CHEMBL5226297";"1";"Scientific Literature";"J Med Chem";"2021";"CHEMBL3308739";"TIME = 72.0 hr";"";"";"10.0"
"CHEMBL103870";"";"None";"443.96";"0";"4.04";"1b";"COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(Cl)cc4)CC3)c2cc1OC";"IC50";"'='";"790.0";"nM";"6.10";"";"";"UO_0000065";"13.75";"0.28";"2.06";"9.67";"0";"CHEMBL768948";"Concentration required for 50% inhibition against autophosphorylation of Platelet-derived growth factor receptor beta in intact cells using a two site ELISA";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2095189";"Platelet-derived growth factor receptor";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL1136005";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"0.79"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386165";"Antiproliferative activity against human HT cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HT";"None";"";"";"";"CHEMBL2366130";"HT";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308143";"";"";"";"0.019"
"CHEMBL2036870";"";"None";"317.35";"0";"3.48";"2h";"Cn1c(-c2ccnc(Nc3cccc(O)c3)n2)nc2ccccc21";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"16.65";"0.30";"1.80";"6.97";"0";"CHEMBL2038024";"Inhibition of recombinant FAK using poly(Glu,Tyr)4 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2695";"Focal adhesion kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034932";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";"";"5.2"
"CHEMBL2103886";"RESCIMETOL";"2.0";"590.67";"1";"4.26";"SID170465875";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2ccc(O)c(OC)c2)[C@@H]1OC";"IC50";"";"10000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3562026";"PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"CHEMBL3308376";"";"";"";"10.0"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"COVC-3894205924";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"MK7965; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4346788";"Inhibition of recombinant CDK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of cyclin by [33P]-ATP-based liquid scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346652";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"1.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909194";"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"Neutrophil";"None";"";"";"";"CHEMBL4071";"Cathepsin G";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308052";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909195";"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"Neutrophil";"None";"";"";"";"CHEMBL248";"Leukocyte elastase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308052";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'<'";"5.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380108";"Cytotoxicity against human SK-BR-3 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-BR-3";"None";"";"";"";"CHEMBL613834";"SK-BR-3";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308062";"";"";"";"0.005"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386179";"Antiproliferative activity against human MCF7 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL387";"MCF7";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308403";"";"";"";"0.006"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"13.76";"0.31";"4.53";"7.90";"0";"CHEMBL3136009";"Inhibition of B-Raf activated MEK1 (unknown origin) assessed as ERK2-mediated MBP phosphorylation after 30 mins by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3132762";"1";"Scientific Literature";"Medchemcomm";"2014";"None";"";"";"";"3.4"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"DIN";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"0";"CHEMBL5136664";"Inhibition of His-tagged CDK2/cyclin E1 (unknown origin) expressed in Sf9 cells using histone H1 as substrate in presence of ATP and [gamma33-P]ATP by radioisotope filter binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1907605";"Cyclin-dependent kinase 2/cyclin E1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5131567";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.003"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909137";"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BTI-TN-5B1-4";"None";"";"";"";"CHEMBL5281";"Cytochrome P450 2E1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833782";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909140";"DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL217";"Dopamine D2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";"";"";"";""
"CHEMBL203170";"";"None";"845.96";"2";"-1.14";"7";"CCCC[C@@H]1NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL867658";"Inhibitory activity against hMC1R transfected in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL3795";"Melanocortin receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138987";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307715";"";"";"";"10000.0"
"CHEMBL2103855";"TELOTRISTAT";"4.0";"546.94";"1";"4.51";"LX-1033";"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"14.25";"0.28";"3.29";"5.48";"1";"CHEMBL3802442";"Inhibition of TPH1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5689";"Tryptophan 5-hydroxylase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"16.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4701888";"Antiproliferative activity against human KYSE-520 cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KYSE-520 cell line";"None";"";"";"";"CHEMBL612701";"KYSE-520 cell line";"Homo sapiens";"CELL-LINE";"CHEMBL4699491";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3307804";"";"";"";"0.01"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL4124403";"Inhibition of CDK9 (unknown origin) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118232";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"4.0"
"CHEMBL2103847";"TOSEDOSTAT";"2.0";"406.48";"0";"1.86";"3";"CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"16.20";"0.31";"4.73";"5.27";"0";"CHEMBL4132608";"Inhibition of recombinant human N-terminal His6-MBP-tagged PSA expressed in Escherichia coli BL21 STAR (DE3) using 4-Ala-MNA as substrate measured for 30 mins by thefluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2264";"Puromycin-sensitive aminopeptidase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130381";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";"";"0.26"
"CHEMBL2103803";"DAROTROPIUM BROMIDE";"None";"425.41";"0";"4.90";"4a";"C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2.[Br-]";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061578";"Antagonist activity against human cloned muscarinic M2 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL211";"Muscarinic acetylcholine receptor M2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153488";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";"";"10.0"
"CHEMBL1203070";"";"None";"440.95";"0";"2.09";"19d";"Cl.O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCNCC1";"IC50";"'='";"14.78";"nM";"7.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL763979";"Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma";"F";"BAO_0000218";"organism-based format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL372";"Homo sapiens";"Homo sapiens";"ORGANISM";"CHEMBL1126868";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";"";"14.78"
"CHEMBL32342";"";"None";"307.28";"0";"2.14";"142";"COc1cc(CC(=O)[O-])c(N)c(C(=O)c2ccccc2)c1.[Na+]";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"18.46";"0.34";"3.13";"5.88";"0";"CHEMBL767496";"Inhibition of prostaglandin G/H synthase obtained from bovine seminal vesicles.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2096674";"Cyclooxygenase";"Bos taurus";"PROTEIN FAMILY";"CHEMBL1122779";"1";"Scientific Literature";"J Med Chem";"1984";"None";"";"";"";"5.4"
"CHEMBL1203810";"";"None";"382.30";"0";"1.92";"15";"CN(C)CCNC(=O)c1cccc2[nH]c(-c3ccccn3)nc12.Cl.Cl";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL754894";"In vitro cell growth inhibitory activity against wild type P388 murine leukemia cell line (P388/W)";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"P388";"None";"";"";"";"CHEMBL389";"P388";"Mus musculus";"CELL-LINE";"CHEMBL1125099";"1";"Scientific Literature";"J Med Chem";"1990";"CHEMBL3308401";"";"";"";"19.0"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"1";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350847";"Inhibition of CYP3A4 (unknown origin)";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL340";"Cytochrome P450 3A4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346624";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"50.0"
"CHEMBL2103852";"CROLIBULIN";"2.0";"417.26";"0";"2.85";"Crolibulin";"COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147472";"Antiproliferative activity against human MKN45 cells after 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MKN-45";"None";"";"";"";"CHEMBL614354";"MKN-45";"Homo sapiens";"CELL-LINE";"CHEMBL4145506";"1";"Scientific Literature";"Eur J Med Chem";"2018";"CHEMBL3307603";"";"";"";"0.17"
"CHEMBL4796268";"";"None";"583.40";"1";"4.51";"Telotristat";"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1.Cl";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"13.15";"0.26";"2.68";"5.06";"0";"CHEMBL4712948";"Inhibition of Tryptophan hydroxylase 1 (unknown origin) incubated for 4 hrs by fluorescence based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5689";"Tryptophan 5-hydroxylase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706651";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";"";"64.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909128";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL2434";"Interleukin-8 receptor B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909130";"DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"Platelet";"None";"";"";"";"CHEMBL221";"Cyclooxygenase-1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833781";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909122";"DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"Chem-1";"Membrane";"";"";"";"CHEMBL218";"Cannabinoid CB1 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909129";"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"1321-N1";"Membrane";"";"";"";"CHEMBL1901";"Cholecystokinin A receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909168";"DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL4608";"Melanocortin receptor 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"Tafamidis";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"3490.0";"nM";"5.46";"";"";"UO_0000065";"17.71";"0.37";"0.96";"8.62";"0";"CHEMBL5382207";"Covalent inhibition of urea-induced Transthyretin denaturation in human plasma preincubated for 1 hr followed by urea addition by Western blot analysis";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"None";"Plasma";"None";"None";"";"";"";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380798";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE_Lower = 0.1 microM | DOSE_Upper = 100.0 microM | TIME = 1.0 hr";"INHIBITOR";"";"3.49"
"CHEMBL2103873";"MACITENTAN";"4.0";"588.28";"1";"3.57";"EUB0000496a";"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1";"IC50";"'='";"391.0";"nM";"6.41";"";"";"UO_0000065";"10.89";"0.27";"2.84";"5.00";"1";"CHEMBL4426324";"Displacement of [125I]-ET-1 from human ETB receptor expressed in CHO cell membranes after 2 hrs by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL1785";"Endothelin receptor ET-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425117";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308072";"";"";"";"391.0"
"CHEMBL2035870";"";"None";"417.46";"0";"-1.33";"4d";"CC(C)[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](N)C1O[C@@H]2OC(C)(C)O[C@@H]2[C@H]1O)C(=O)O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2038194";"Inhibition of South African HIV1 subtype C protease expressed in Escherichia coli BL21S4 (DE3)pLysS cells using Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 as substrate by spectrophotometry";"B";"BAO_0000219";"cell-based format";"Human immunodeficiency virus 1";"None";"None";"None";"None";"";"";"";"CHEMBL2366517";"Protease";"Human immunodeficiency virus 1";"SINGLE PROTEIN";"CHEMBL2034816";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";"";"10000.0"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992025";"Potentiation of etoposide induced DNA damage in human DMS114 cells expressing Rad51 assessed as etoposide IC50 at 0.25 uM (Rvb IC50 = 0.92 uM)";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DMS-114";"None";"";"";"";"CHEMBL614642";"DMS-114";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3307670";"";"";"";"0.23"
"CHEMBL2103881";"DEXMECAMYLAMINE";"3.0";"167.30";"0";"2.42";"13, TC-5214";"CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"35.39";"0.67";"3.50";"49.22";"0";"CHEMBL3363159";"Antagonist activity at human alpha7 nAChR";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2492";"Neuronal acetylcholine receptor protein alpha-7 subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352239";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"1.2"
"CHEMBL160340";"";"None";"542.71";"0";"4.15";"19";"CCCc1ccc(Oc2cccc(CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-])c2)cc1.[K+].[K+].[K+]";"IC50";"'='";"14200.0";"nM";"4.85";"";"";"UO_0000065";"11.31";"0.24";"0.70";"4.00";"0";"CHEMBL808970";"Inhibitory activity against rat liver microsomal squalene synthase was determined using [3H]FPP as radioligand";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3815";"Squalene synthetase";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1129470";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";"";"14200.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL5230720";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230096";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"4.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5353306";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352406";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103760";"AZAMULIN";"2.0";"478.66";"0";"3.61";"Azamulin";"CC[C@]1(C)C[C@@H](OC(=O)CSc2nnc(N)[nH]2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4773119";"Inhibition of CYP450 (unknown origin)";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4765405";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"0.12"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4124400";"Inhibition of CDK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118232";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"1.0"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"10.97";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5109755";"Cytotoxicity against KK-LC-1-positive human NUGC-4 cells incubated for 72 hrs by CCK-8 assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NUGC-4";"None";"";"";"";"CHEMBL613519";"NUGC-4";"Homo sapiens";"CELL-LINE";"CHEMBL5108004";"1";"Scientific Literature";"Eur J Med Chem";"2022";"CHEMBL3307267";"TIME = 72.0 hr";"";"";"10.97"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"10.7";"nM";"7.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5109756";"Cytotoxicity against KK-LC-1-positive human MKN-45 cells incubated for 72 hrs by CCK-8 assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MKN-45";"None";"";"";"";"CHEMBL614354";"MKN-45";"Homo sapiens";"CELL-LINE";"CHEMBL5108004";"1";"Scientific Literature";"Eur J Med Chem";"2022";"CHEMBL3307603";"TIME = 72.0 hr";"";"";"10.7"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"14.29";"0.32";"4.86";"8.21";"0";"CHEMBL5478720";"Selectivity interaction (ELISA (Raf-MEK-ERK cascade kinase assay, activated with B-Raf)) EUB0000124b MAP2K2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Remarks: In-vitro potency (using 10 uM ATP) | Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"1.6"
"CHEMBL2103852";"CROLIBULIN";"2.0";"417.26";"0";"2.85";"Crolibulin";"COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147471";"Antiproliferative activity against human A549 cells after 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL4145506";"1";"Scientific Literature";"Eur J Med Chem";"2018";"CHEMBL3307651";"";"";"";"0.39"
"CHEMBL3827679";"";"None";"551.45";"0";"1.74";"1";"Cl.Cl.N=C(N)N/N=C/c1c(-c2ccccc2)nc2n1ccc1nc(-c3ccccc3)c(/C=N/NC(=N)N)n12";"IC50";"'='";"101000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3830999";"Cytotoxicity against human U2OS cells assessed as cell killing after 1 hr by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL615023";"U2OS";"Homo sapiens";"CELL-LINE";"CHEMBL3826876";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307757";"";"";"";"101.0"
"CHEMBL4103870";"";"None";"363.44";"1";"5.43";"12f";"O=C(c1ccc([N+](=O)[O-])cc1)c1c(-c2ccccc2)sc2c1CCCC2";"IC50";"'='";"24220.0";"nM";"4.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3994726";"Antiproliferative activity against human A549 cells after 48 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL3994563";"1";"Scientific Literature";"Medchemcomm";"2016";"CHEMBL3307651";"";"";"";"24.22"
"CHEMBL4103870";"";"None";"363.44";"1";"5.43";"12f";"O=C(c1ccc([N+](=O)[O-])cc1)c1c(-c2ccccc2)sc2c1CCCC2";"IC50";"'='";"14610.0";"nM";"4.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3994727";"Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PC-3";"None";"";"";"";"CHEMBL390";"PC-3";"Homo sapiens";"CELL-LINE";"CHEMBL3994563";"1";"Scientific Literature";"Medchemcomm";"2016";"CHEMBL3307570";"";"";"";"14.61"
"CHEMBL1203830";"";"None";"382.30";"0";"1.92";"23";"CN(C)CCNC(=O)c1cccc2[nH]c(-c3ccncc3)nc12.Cl.Cl";"IC50";"'='";"15900.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL754895";"In vitro cell growth inhibitory activity against amsacrine-resistant P388 cell line (P388/A)";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"P388";"None";"";"";"";"CHEMBL389";"P388";"Mus musculus";"CELL-LINE";"CHEMBL1125099";"1";"Scientific Literature";"J Med Chem";"1990";"CHEMBL3308401";"";"";"";"15.9"
"CHEMBL203170";"";"None";"845.96";"2";"-1.14";"7";"CCCC[C@@H]1NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL867659";"Inhibitory activity against hMC3R transfected in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4644";"Melanocortin receptor 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138987";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307715";"";"";"";"10000.0"
"CHEMBL2103803";"DAROTROPIUM BROMIDE";"None";"425.41";"0";"4.90";"4a";"C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2.[Br-]";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061577";"Antagonist activity against human cloned muscarinic M1 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL216";"Muscarinic acetylcholine receptor M1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153488";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";"";"10.0"
"CHEMBL2103856";"ATOPAXAR";"2.0";"527.64";"1";"4.79";"Atopaxar";"CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4224007";"Antagonist activity at PAR1 in human EAhy926 cells assessed as inhibition of TFLLRN-NH2-induced intracellular calcium mobilization pretreated for 15 mins followed by TFLLRN-NH2 addition measured at 5 secs interval for 250 secs by Fluo-4/AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3974";"Proteinase-activated receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219243";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"0.033"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"'='";"219.7";"nM";"6.66";"";"";"UO_0000065";"21.31";"0.40";"2.78";"17.85";"0";"CHEMBL1909191";"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)";"B";"BAO_0000221";"tissue-based format";"Bos taurus";"CHEMBL3638197";"Uterus";"None";"None";"";"";"";"CHEMBL1909044";"Progesterone receptor";"Bos taurus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";"0.2197"
"CHEMBL2103886";"RESCIMETOL";"2.0";"590.67";"1";"4.26";"SID170465875";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2ccc(O)c(OC)c2)[C@@H]1OC";"IC50";"";"10000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3562139";"PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"CHEMBL3308376";"";"";"";"10.0"
"CHEMBL1203820";"";"None";"395.33";"0";"2.83";"28";"Cc1cc(C(=O)NCCN(C)C)c2nc(-c3ccccc3)[nH]c2c1.Cl.Cl";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL754894";"In vitro cell growth inhibitory activity against wild type P388 murine leukemia cell line (P388/W)";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"P388";"None";"";"";"";"CHEMBL389";"P388";"Mus musculus";"CELL-LINE";"CHEMBL1125099";"1";"Scientific Literature";"J Med Chem";"1990";"CHEMBL3308401";"";"";"";"21.0"
"CHEMBL1203820";"";"None";"395.33";"0";"2.83";"28";"Cc1cc(C(=O)NCCN(C)C)c2nc(-c3ccccc3)[nH]c2c1.Cl.Cl";"IC50";"'='";"22400.0";"nM";"4.65";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL754895";"In vitro cell growth inhibitory activity against amsacrine-resistant P388 cell line (P388/A)";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"P388";"None";"";"";"";"CHEMBL389";"P388";"Mus musculus";"CELL-LINE";"CHEMBL1125099";"1";"Scientific Literature";"J Med Chem";"1990";"CHEMBL3308401";"";"";"";"22.4"
"CHEMBL1203860";"";"None";"503.46";"1";"5.87";"64";"Cl.Cl.Fc1ccc(C2CC(N3CCN(C/C=C/c4ccccc4)CC3)c3cc(F)ccc32)cc1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL750459";"Effect on synaptosomal uptake inhibition of Noradrenaline (NA);NT = Not Tested";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2095166";"Adrenergic receptor beta";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";""
"CHEMBL2103886";"RESCIMETOL";"2.0";"590.67";"1";"4.26";"SID170465875";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2ccc(O)c(OC)c2)[C@@H]1OC";"IC50";"";"10000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3562120";"PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"CHEMBL3308376";"";"";"";"10.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909107";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808)";"B";"BAO_0000249";"cell membrane format";"Cavia porcellus";"CHEMBL3638255";"Striatum";"None";"Membrane";"";"";"";"CHEMBL5017";"Serotonin 4 (5-HT4) receptor";"Cavia porcellus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.068";"nM";"10.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5151311";"Cytotoxicity against HEK293T cells assessed as inhibition in cell growth";"T";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-293T";"None";"";"";"";"CHEMBL3706568";"HEK-293T";"Homo sapiens";"CELL-LINE";"CHEMBL5149986";"1";"Scientific Literature";"J Nat Prod";"2021";"CHEMBL3706569";"";"";"";"0.068"
"CHEMBL2103772";"RACECADOTRIL";"4.0";"385.49";"0";"2.98";"racecadotril";"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1";"IC50";"'='";"1270000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162021";"Cytotoxicity against drug-resistant human KBV1 cells expressing P-gp incubated for 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KB-V1";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL2157950";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL4295414";"";"";"";"1.27"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880512";"Growth inhibition of human SW1573 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW1573";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307980";"";"";"";"1.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880516";"Growth inhibition of human HCC827 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCC827";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL4295384";"";"";"";"1.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909093";"DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL246";"Beta-3 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909100";"DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"Chem-1";"Membrane";"";"";"";"CHEMBL3157";"Bradykinin B2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909127";"DRUGMATRIX: Chemokine CXCR1 (IL-8A)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4029";"Interleukin-8 receptor A";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909136";"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BTI-TN-5B1-4";"None";"";"";"";"CHEMBL289";"Cytochrome P450 2D6";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833782";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909144";"DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL252";"Endothelin receptor ET-A";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"'='";"433.3";"nM";"6.36";"";"";"UO_0000065";"20.37";"0.38";"2.48";"17.06";"0";"CHEMBL1909145";"DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL206";"Estrogen receptor alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308860";"";"";"";"0.4333"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909085";"DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3987361";"Submaxillary gland";"None";"Membrane";"";"";"";"CHEMBL319";"Alpha-1a adrenergic receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909208";"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)";"B";"BAO_0000249";"cell membrane format";"Oryctolagus cuniculus";"CHEMBL3638205";"Urinary bladder";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909210";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"Membrane";"";"";"";"CHEMBL3459";"Serotonin 1b (5-HT1b) receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909211";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL224";"Serotonin 2a (5-HT2a) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909178";"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)";"B";"BAO_0000221";"tissue-based format";"Rattus norvegicus";"CHEMBL3638233";"Cerebellum";"None";"None";"";"";"";"CHEMBL3048";"Nitric-oxide synthase, brain";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909184";"DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"Platelet";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833781";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909183";"DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu)";"B";"BAO_0000249";"cell membrane format";"Mus musculus";"CHEMBL3638188";"Brain";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909199";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)";"B";"BAO_0000357";"single protein format";"Escherichia coli";"None";"None";"None";"None";"";"";"";"CHEMBL3385";"MAP kinase ERK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2163870";"";"None";"387.44";"0";"2.40";"46a";"O=c1ccn(CCCc2cnnn2C(c2ccccc2)c2ccccc2)c(=O)[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2169084";"Inhibition of human dUTPase assessed as reduction in [5-3H]dUMP production incubated for 15 mins by HPLC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5203";"dUTP pyrophosphatase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163292";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"10.0"
"CHEMBL173870";"";"None";"508.57";"2";"-0.02";"2";"CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C";"IC50";"'='";"51000.0";"nM";"4.29";"";"";"UO_0000065";"8.44";"0.16";"4.31";"2.06";"0";"CHEMBL823497";"Inhibition of integrin alpha4-beta1 adhesion to Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL1907599";"Integrin alpha-4/beta-1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL1132287";"1";"Scientific Literature";"J Med Chem";"1999";"CHEMBL3307526";"";"";"";"51000.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380101";"Cytotoxicity against human U266 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-266";"None";"";"";"";"CHEMBL2366315";"U-266";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308535";"";"";"";"0.006"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380104";"Cytotoxicity against human SK-UT-1 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-UT-1";"None";"";"";"";"CHEMBL2366316";"SK-UT-1";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308848";"";"";"";"0.006"
"CHEMBL2103860";"USISTAPIDE";"2.0";"572.63";"2";"7.72";"COVC-2826366254";"COC(=O)[C@H](c1ccccc1)N1CCC(c2ccc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)cc2)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909147";"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3638188";"Brain";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909149";"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"17.68";"0.33";"1.64";"14.81";"0";"CHEMBL1909134";"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BTI-TN-5B1-4";"None";"";"";"";"CHEMBL3622";"Cytochrome P450 2C19";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833782";"";"";"";"3.0"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421238";"Antiproliferative activity against human KB cells after 4 days by XTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KB";"None";"";"";"";"CHEMBL398";"KB";"Homo sapiens";"CELL-LINE";"CHEMBL2417433";"1";"Scientific Literature";"Eur J Med Chem";"2013";"CHEMBL3307959";"";"";"";"0.19"
"CHEMBL1202870";"";"None";"387.36";"0";"3.19";"4k";"Cl.Cl.O.c1ccc(CN2CCC(CCNc3cccnn3)CC2)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"22.33";"0.41";"3.43";"16.13";"0";"CHEMBL642727";"In vitro inhibition of electric eel acetylcholinesterase";"B";"BAO_0000357";"single protein format";"Electrophorus electricus";"None";"None";"None";"None";"";"";"";"CHEMBL4078";"Acetylcholinesterase";"Electrophorus electricus";"SINGLE PROTEIN";"CHEMBL1134774";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";"";"240.0"
"CHEMBL160340";"";"None";"542.71";"0";"4.15";"6";"CCCc1ccc(Oc2cccc(CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-])c2)cc1.[K+].[K+].[K+]";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"13.35";"0.28";"1.57";"4.72";"0";"CHEMBL941165";"Inhibition of human recombinant squalene synthase expressed in Escherichia coli BL21 (DE3) cells assessed as formation of 1,10-dioic acid metabolite by liquid scintillation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL3338";"Squalene synthetase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140905";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";"";"1.9"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"7860.0";"nM";"5.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992017";"Cytotoxic activity in human NCI-H647 cells expressing Rad51";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H647";"None";"";"";"";"CHEMBL614999";"NCI-H647";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3308691";"";"";"";"7.86"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"15.41";"0.29";"3.60";"9.09";"0";"CHEMBL3992004";"Inhibition of cKIT V654A mutant (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"P10721";"V654A";"CHEMBL1936";"Stem cell growth factor receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"None";"";"";"";"0.127"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'<'";"300.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992016";"Potentiation of carboplatin induced DNA damage in human A549 cells expressing Rad51 assessed as carboplatin IC50 at 3.82 uM (Rvb IC50 = 20.14 uM)";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3307651";"";"";"";"0.3"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992023";"Cytotoxic activity in human DMS114 cells expressing Rad51";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DMS-114";"None";"";"";"";"CHEMBL614642";"DMS-114";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3307670";"";"";"";"0.98"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880501";"Growth inhibition of human HT-29 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HT-29";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307768";"";"";"";"0.002"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880531";"Growth inhibition of human HT-29 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HT-29";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307768";"";"";"";"0.001"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880533";"Growth inhibition of human SW1417 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW1417";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308129";"";"";"";"0.003"
"CHEMBL173870";"";"None";"508.57";"2";"-0.02";"2";"CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C";"IC50";"'='";"12600.0";"nM";"4.90";"";"";"UO_0000065";"9.63";"0.19";"4.92";"2.35";"0";"CHEMBL823344";"Inhibition of integrin alpha4-beta1 binding to VCAM-Ig";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907599";"Integrin alpha-4/beta-1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL1132287";"1";"Scientific Literature";"J Med Chem";"1999";"None";"";"";"";"12600.0"
"CHEMBL2036870";"";"None";"317.35";"0";"3.48";"2h";"Cn1c(-c2ccnc(Nc3cccc(O)c3)n2)nc2ccccc21";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"17.31";"0.31";"2.01";"7.24";"0";"CHEMBL2038025";"Inhibition of recombinant VEGFR2 using poly(Glu,Tyr)4 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL279";"Vascular endothelial growth factor receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034932";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";"";"3.2"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"5.32";"nM";"8.27";"";"";"UO_0000065";"20.87";"0.39";"5.99";"8.93";"0";"CHEMBL5353921";"Inhibition of CDK1 (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"5.32"
"CHEMBL2012870";"";"None";"323.36";"0";"1.25";"15f";"O=c1[nH]nc2cc(CNCCO)c3ccc(-c4ccc[nH]4)cc3n12";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"23.26";"0.43";"6.27";"7.66";"0";"CHEMBL2013769";"Inhibition of Chk1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4630";"Serine/threonine-protein kinase Chk1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010637";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"0.03"
"CHEMBL2013170";"";"None";"445.50";"0";"3.23";"32";"NCNC(=O)c1cncc(-c2cnc(Nc3cc(N4CCC(F)(F)CC4)ccn3)s2)c1";"IC50";"'='";"0.05";"nM";"10.30";"";"";"UO_0000065";"23.12";"0.45";"7.07";"9.45";"0";"CHEMBL2014579";"Inhibition of CHK1 by time resolved fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4630";"Serine/threonine-protein kinase Chk1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010672";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"0.05"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992021";"Potentiation of etoposide induced DNA damage in human DMS153 cells expressing Rad51 assessed as etoposide IC50 at 0.044 uM (Rvb IC50 = 0.29 uM)";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DMS-153";"None";"";"";"";"CHEMBL2366167";"DMS-153";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3308260";"";"";"";"0.24"
"CHEMBL319739";"";"None";"506.49";"0";"3.63";"44";"CC(C)n1nnnc1C(/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])=C(c1ccc(F)cc1)c1ccc(F)cc1.[Na+]";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"10.02";"0.19";"1.22";"4.00";"0";"CHEMBL691797";"In vitro inhibitory activity was measured against rat liver HMG-CoA reductase";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3247";"HMG-CoA reductase";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1125005";"1";"Scientific Literature";"J Med Chem";"1990";"None";"";"";"";"14.0"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.62";"nM";"9.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5152798";"Cytotoxicity against human DU-145 cells assessed as reduction in cell viability incubated for 72 hrs in presence of TTR by CellTiter-96 assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DU-145";"None";"";"";"";"CHEMBL613508";"DU-145";"Homo sapiens";"CELL-LINE";"CHEMBL5150030";"1";"Scientific Literature";"J Med Chem";"2022";"CHEMBL3308034";"TIME = 72.0 hr";"";"";"0.62"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909123";"DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA))";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"Erythrocyte";"None";"";"";"";"CHEMBL205";"Carbonic anhydrase II";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833281";"";"";"";""
"CHEMBL2031870";"";"None";"405.54";"0";"3.59";"35";"CC(C)NC(=O)c1ccc(-c2ccc3c(c2)CCN(CCN2CCCC2)C3=O)cc1";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"12.84";"0.24";"1.62";"9.89";"0";"CHEMBL2034394";"Inhibition of human ERG by IonWorks assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL240";"HERG";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029265";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"6.2"
"CHEMBL203879";"";"None";"556.75";"2";"0.85";"XV";"COC(=O)[C@H](CCSC)NC(=O)[C@@H](Cc1ccc(O)c(C)c1C)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C";"IC50";"'='";"70500.0";"nM";"4.15";"";"";"UO_0000065";"7.46";"0.15";"3.30";"2.60";"0";"CHEMBL862032";"Inhibitory activity against farnesyl transferase";"B";"BAO_0000223";"protein complex format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2094108";"Protein farnesyltransferase";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL1138191";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"70.5"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"1";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5227184";"Anticancer activity against human MDA-MB-453 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-453";"None";"";"";"";"CHEMBL614334";"MDA-MB-453";"Homo sapiens";"CELL-LINE";"CHEMBL5226297";"1";"Scientific Literature";"J Med Chem";"2021";"CHEMBL3307596";"TIME = 72.0 hr";"";"";"0.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909143";"DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL238";"Dopamine transporter";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909108";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HeLa";"Membrane";"";"";"";"CHEMBL3371";"Serotonin 6 (5-HT6) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308376";"";"";"";""
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5152800";"Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs in presence of TTR by CellTiter-96 assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL399";"HeLa";"Homo sapiens";"CELL-LINE";"CHEMBL5150030";"1";"Scientific Literature";"J Med Chem";"2022";"CHEMBL3308376";"TIME = 72.0 hr";"";"";"1.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909177";"DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"IMR-32";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307656";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909185";"DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"U-937";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308006";"";"";"";""
"CHEMBL2103886";"RESCIMETOL";"2.0";"590.67";"1";"4.26";"SID170465875";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2ccc(O)c(OC)c2)[C@@H]1OC";"IC50";"";"10000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3562115";"PubChem BioAssay. Increased HeLa cells in S-phase-IC50.   (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"CHEMBL3308376";"";"";"";"10.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909167";"DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL259";"Melanocortin receptor 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909212";"DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL220";"Acetylcholinesterase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5152797";"Cytotoxicity against human DU-145 cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter-96 assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DU-145";"None";"";"";"";"CHEMBL613508";"DU-145";"Homo sapiens";"CELL-LINE";"CHEMBL5150030";"1";"Scientific Literature";"J Med Chem";"2022";"CHEMBL3308034";"TIME = 72.0 hr";"";"";"0.55"
"CHEMBL160340";"";"None";"542.71";"0";"4.15";"6";"CCCc1ccc(Oc2cccc(CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-])c2)cc1.[K+].[K+].[K+]";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"13.21";"0.28";"1.51";"4.67";"0";"CHEMBL941163";"Inhibition of Staphylococcus aureus dehydrosqualene synthase expressed in Escherichia coli BL21 (DE3) cells by continuous spectrophotometric assay";"B";"BAO_0000219";"cell-based format";"Staphylococcus aureus";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL5440";"Dehydrosqualene synthase";"Staphylococcus aureus";"SINGLE PROTEIN";"CHEMBL1140905";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";"";"2.2"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880535";"Growth inhibition of human A549 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307651";"";"";"";"0.016"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880538";"Growth inhibition of human NCI-H23 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H23";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307750";"";"";"";"0.02"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"1820.0";"nM";"5.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5352094";"Cytotoxicity against AML12 cells incubated for 72 hrs measured by MTT assay";"T";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"AML12";"None";"";"";"";"CHEMBL5058625";"AML12";"Mus musculus";"CELL-LINE";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"CHEMBL5058603";"TIME = 72.0 hr";"";"";"1.82"
"CHEMBL1203860";"";"None";"503.46";"1";"5.87";"63";"Cl.Cl.Fc1ccc(C2CC(N3CCN(C/C=C/c4ccccc4)CC3)c3cc(F)ccc32)cc1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL750459";"Effect on synaptosomal uptake inhibition of Noradrenaline (NA);NT = Not Tested";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2095166";"Adrenergic receptor beta";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";""
"CHEMBL1203860";"";"None";"503.46";"1";"5.87";"63";"Cl.Cl.Fc1ccc(C2CC(N3CCN(C/C=C/c4ccccc4)CC3)c3cc(F)ccc32)cc1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL615858";"Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT)";"F";"BAO_0000019";"assay format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL313";"Serotonin transporter";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";"160.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"20.52";"0.38";"5.73";"7.84";"0";"CHEMBL5352090";"Inhibition of human recombinant HDAC1 using fluorogenic Boc-Lys (aetyl)-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 2 hrs by measuring fluorescence intensity using multimode microplate reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL325";"Histone deacetylase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.167 hr";"INHIBITOR";"";"7.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"1010.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5352093";"Cytotoxicity against human Huh-7 cells incubated for 72 hrs measured by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Huh-7";"None";"";"";"";"CHEMBL614039";"Huh-7";"Homo sapiens";"CELL-LINE";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"CHEMBL3307515";"TIME = 72.0 hr";"";"";"1.01"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"39.2";"nM";"7.41";"";"";"UO_0000065";"18.64";"0.35";"4.99";"7.12";"0";"CHEMBL5352095";"Inhibition of HDAC2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1937";"Histone deacetylase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"39.2"
"CHEMBL3827679";"";"None";"551.45";"0";"1.74";"1";"Cl.Cl.N=C(N)N/N=C/c1c(-c2ccccc2)nc2n1ccc1nc(-c3ccccc3)c(/C=N/NC(=N)N)n12";"IC50";"'='";"5120.0";"nM";"5.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3831002";"Cytotoxicity against human HCT116 cells assessed as cell killing after 24 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3826876";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308372";"";"";"";"5.12"
"CHEMBL2103860";"USISTAPIDE";"2.0";"572.63";"2";"7.72";"COVC-2826366254";"COC(=O)[C@H](c1ccccc1)N1CCC(c2ccc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)cc2)CC1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5132027";"Antiviral activity against SARS-CoV-2 in human A549-ACE2 cells assessed as inhibition of viral growth";"F";"BAO_0000218";"organism-based format";"Severe acute respiratory syndrome coronavirus 2";"None";"None";"A549-ACE2";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL5131378";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"";"";"0.032"
"CHEMBL2010387";"";"None";"527.57";"2";"0.47";"BDBM136693";"CN(C)C1C(O)=C(C(=O)NCN2CCCC2)C(=O)C2(O)C(O)=C3C(=O)c4c(O)cccc4C(C)(O)C3CC12";"IC50";"'='";"84000.0";"nM";"4.08";"";"270572";"UO_0000065";"7.73";"0.15";"3.61";"2.39";"0";"CHEMBL3706220";"Gel-Based Assay: Assay: Unless indicated otherwise, Tdp1 assays were performed in 20 ul mixtures containing 50 mM Tris-HCl, pH 8.0, 80 mM KCl, 2 mM EDTA, 1 mM dithiothreitol (DTT), and 40 ug/ml bovine serum albumin (BSA). For initial screening of Tdp1 inhibitors, 25 nM of 5'-32P-labeled substrate (D14Y) was reacted with 1 ng Tdp1 (~0.7 nM) in the absence or presence of inhibitor for 20 min at 25 C. Reactions were stopped by addition of 60 ul of gel loading buffer (98% (v/v) formamide, 1% (w/v) xylene cyanol, 1% (w/v) bromophenol blue). Twelve ul of aliquots were resolved in 20% denaturing polyacrylamide (AccuGel, National Diagnostics, Atlanta, Ga.) (19:1) gel containing 7 M urea. After drying, gels were exposed overnight to PhosphorImager screens (Molecular Dynamics, Sunnyvale, Calif.). Screens were scanned, and images were obtained with the Molecular Dynamics software (Sunnyvale, Calif.). Densitometry analyses were performed using ImageQuant 5.2 software package.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1075138";"Tyrosyl-DNA phosphodiesterase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638471";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"84000.0"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4255617";"Cytotoxicity against human 293T cells assessed as reduction in cell viability after 72 hrs by resazurin dye based Alamar blue assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-293T";"None";"";"";"";"CHEMBL3706568";"HEK-293T";"Homo sapiens";"CELL-LINE";"CHEMBL4251686";"1";"Scientific Literature";"J Nat Prod";"2018";"CHEMBL3706569";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909151";"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5352098";"Inhibition of HDAC4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3524";"Histone deacetylase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"1000.0"
"CHEMBL3989516";"FOSTAMATINIB DISODIUM";"4.0";"732.52";"2";"3.09";"1";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)([O-])[O-])C(=O)C(C)(C)O4)n2)cc(OC)c1OC.O.O.O.O.O.O.[Na+].[Na+]";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.38";"0.27";"4.68";"4.16";"0";"CHEMBL2189057";"Inhibition of human recombinant spleen tyrosine kinase (360 to 635 amino acid residues) after 10 mins by scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2599";"Tyrosine-protein kinase SYK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176924";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"17.0"
"CHEMBL203870";"";"None";"319.41";"0";"3.83";"5i";"C(=C\n1ncc2c(N3CCCCCC3)ncnc21)\c1ccccc1";"IC50";"'='";"60900.0";"nM";"4.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL864339";"Antiproliferative activity against A431 cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A-431";"None";"";"";"";"CHEMBL614069";"A-431";"Homo sapiens";"CELL-LINE";"CHEMBL1138181";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307523";"";"";"";"60.9"
"CHEMBL203870";"";"None";"319.41";"0";"3.83";"5i";"C(=C\n1ncc2c(N3CCCCCC3)ncnc21)\c1ccccc1";"IC50";"'='";"93700.0";"nM";"4.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL864340";"Antiproliferative activity against 8701-BC cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"8701-BC";"None";"";"";"";"CHEMBL614777";"8701-BC";"Homo sapiens";"CELL-LINE";"CHEMBL1138181";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307701";"";"";"";"93.7"
"CHEMBL1210370";"";"None";"544.07";"2";"5.73";"25a";"CC[C@H](C)[C@H](NC(=O)N1CCC2(CC1)C(=O)N(c1cccc(F)c1)C2c1ccc(Cl)cc1)C(=O)OC(C)C";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"13.50";"0.26";"1.62";"9.31";"0";"CHEMBL1212315";"Inhibition of human CaV3.2 expressed in HEK293 cells at -100 mV membrane potential by Ionworks HT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL1859";"Voltage-gated T-type calcium channel alpha-1H subunit";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208707";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3307715";"";"";"";"45.0"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5371247";"Antiproliferative activity against mouse GL26 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"GL26";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5370536";"1";"Scientific Literature";"Eur J Med Chem";"2023";"None";"TIME = 48.0 hr";"";"";"0.003"
"CHEMBL2103760";"AZAMULIN";"2.0";"478.66";"0";"3.61";"Azamulin";"CC[C@]1(C)C[C@@H](OC(=O)CSc2nnc(N)[nH]2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"13.83";"0.27";"3.01";"5.05";"0";"CHEMBL4818570";"Inhibition of CYP3A4 in human liver microsomes using testosterone as substrate incubated for 10 mins by LC/MS/MS analysis";"B";"BAO_0000251";"microsome format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL340";"Cytochrome P450 3A4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4814060";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";"";"0.24"
"CHEMBL103870";"";"None";"443.96";"0";"4.04";"49";"COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(Cl)cc4)CC3)c2cc1OC";"IC50";"'='";"790.0";"nM";"6.10";"";"";"UO_0000065";"13.75";"0.28";"2.06";"9.67";"0";"CHEMBL768951";"Inhibition of Platelet-derived growth factor receptor beta phosphorylation";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1913";"Platelet-derived growth factor receptor beta";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135502";"1";"Scientific Literature";"J Med Chem";"2002";"None";"";"";"";"0.79"
"CHEMBL1203807";"";"None";"395.33";"0";"2.83";"20";"Cc1ccc(-c2nc3c(C(=O)NCCN(C)C)cccc3[nH]2)cc1.Cl.Cl";"IC50";"'='";"12500.0";"nM";"4.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL754895";"In vitro cell growth inhibitory activity against amsacrine-resistant P388 cell line (P388/A)";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"P388";"None";"";"";"";"CHEMBL389";"P388";"Mus musculus";"CELL-LINE";"CHEMBL1125099";"1";"Scientific Literature";"J Med Chem";"1990";"CHEMBL3308401";"";"";"";"12.5"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"19.42";"0.36";"5.42";"8.31";"0";"CHEMBL5256976";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252675";"1";"Scientific Literature";"RSC Med Chem";"2023";"None";"";"INHIBITOR";"";"20.0"
"CHEMBL3827679";"";"None";"551.45";"0";"1.74";"1";"Cl.Cl.N=C(N)N/N=C/c1c(-c2ccccc2)nc2n1ccc1nc(-c3ccccc3)c(/C=N/NC(=N)N)n12";"IC50";"'='";"35070.0";"nM";"4.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3831000";"Cytotoxicity against human HCT116 cells assessed as cell killing after 1 hr by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3826876";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308372";"";"";"";"35.07"
"CHEMBL1203810";"";"None";"382.30";"0";"1.92";"15";"CN(C)CCNC(=O)c1cccc2[nH]c(-c3ccccn3)nc12.Cl.Cl";"IC50";"'='";"30200.0";"nM";"4.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL754895";"In vitro cell growth inhibitory activity against amsacrine-resistant P388 cell line (P388/A)";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"P388";"None";"";"";"";"CHEMBL389";"P388";"Mus musculus";"CELL-LINE";"CHEMBL1125099";"1";"Scientific Literature";"J Med Chem";"1990";"CHEMBL3308401";"";"";"";"30.2"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4124401";"Inhibition of CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118232";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"1.0"
"CHEMBL210370";"";"None";"646.93";"3";"5.62";"6d";"N=C(NCCCNCCCCNCCCNC(=N)NCC(c1ccccc1)c1ccccc1)NCC(c1ccccc1)c1ccccc1";"IC50";"'='";"3350.0";"nM";"5.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869333";"Antitrypanosomal activity against Trypanosoma brucei brucei";"F";"BAO_0000218";"organism-based format";"Trypanosoma brucei brucei";"None";"None";"None";"None";"";"";"";"CHEMBL612851";"Trypanosoma brucei brucei";"Trypanosoma brucei brucei";"ORGANISM";"CHEMBL1148496";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";"";"3.35"
"CHEMBL210370";"";"None";"646.93";"3";"5.62";"6d";"N=C(NCCCNCCCCNCCCNC(=N)NCC(c1ccccc1)c1ccccc1)NCC(c1ccccc1)c1ccccc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869332";"Inhibition of human glutathione reductase";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2755";"Glutathione reductase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148496";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";"";"100.0"
"CHEMBL2103760";"AZAMULIN";"2.0";"478.66";"0";"3.61";"Azamulin";"CC[C@]1(C)C[C@@H](OC(=O)CSc2nnc(N)[nH]2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5355343";"Inhibition of CYP3A4 in human liver microsomes using testosterone as substrate incubated for 10 mins by HPLC analysis";"A";"BAO_0000251";"microsome format";"Homo sapiens";"None";"Liver";"None";"Microsome";"";"";"";"CHEMBL340";"Cytochrome P450 3A4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352460";"1";"Scientific Literature";"Eur J Med Chem";"2023";"None";"TIME = 0.1667 hr";"INHIBITOR";"";"0.24"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"1";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5227180";"Anticancer activity against human MDA-MB-468 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-468";"None";"";"";"";"CHEMBL614335";"MDA-MB-468";"Homo sapiens";"CELL-LINE";"CHEMBL5226297";"1";"Scientific Literature";"J Med Chem";"2021";"CHEMBL3308424";"TIME = 72.0 hr";"";"";"0.0"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"1";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5227181";"Anticancer activity against human HCC1937 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCC1937";"None";"";"";"";"CHEMBL1075458";"HCC1937";"Homo sapiens";"CELL-LINE";"CHEMBL5226297";"1";"Scientific Literature";"J Med Chem";"2021";"CHEMBL3308371";"TIME = 72.0 hr";"";"";"20.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"2.09";"nM";"8.68";"";"";"UO_0000065";"21.89";"0.41";"6.40";"9.37";"0";"CHEMBL5353923";"Inhibition of CDK5 (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"2.09"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5353919";"Antiproliferative activity against human MDA-PATC53 cells assessed as growth inhibition incubated for 24 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-PATC53";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"CHEMBL5465443";"TIME = 24.0 hr";"";"";"0.024"
"CHEMBL1203890";"";"None";"445.38";"0";"3.54";"71";"CC(O)CN1CCN(C2CC(c3ccc(F)cc3)c3ccc(F)cc32)CC1.Cl.Cl";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL816027";"Ability to displace [3H]haloperidol from rat striatal membranes, in order to measure its intrinsic affinity for the dopamine (DA) receptor;NT=Not Tested";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2093868";"Dopamine receptor";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";""
"CHEMBL1203860";"";"None";"503.46";"1";"5.87";"64";"Cl.Cl.Fc1ccc(C2CC(N3CCN(C/C=C/c4ccccc4)CC3)c3cc(F)ccc32)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL615858";"Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT)";"F";"BAO_0000019";"assay format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL313";"Serotonin transporter";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";"400.0"
"CHEMBL1203860";"";"None";"503.46";"1";"5.87";"64";"Cl.Cl.Fc1ccc(C2CC(N3CCN(C/C=C/c4ccccc4)CC3)c3cc(F)ccc32)cc1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL816027";"Ability to displace [3H]haloperidol from rat striatal membranes, in order to measure its intrinsic affinity for the dopamine (DA) receptor;NT=Not Tested";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2093868";"Dopamine receptor";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";""
"CHEMBL1208870";"";"None";"337.28";"0";"2.73";"23";"N#Cc1c(-c2cccs2)[n+]([O-])c2ccc(C(F)(F)F)cc2[n+]1[O-]";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1212085";"Antitrypanosomal activity against Trypanosoma cruzi Tulahuen 2 epimastigotes";"F";"BAO_0000218";"organism-based format";"Trypanosoma cruzi";"None";"None";"None";"None";"";"";"";"CHEMBL368";"Trypanosoma cruzi";"Trypanosoma cruzi";"ORGANISM";"CHEMBL1208769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"7.8"
"CHEMBL1203870";"";"None";"440.37";"0";"4.07";"79";"Cl.Cl.N#CCCN1CCN(C2CC(c3ccc(F)cc3)c3ccc(F)cc32)CC1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL816027";"Ability to displace [3H]haloperidol from rat striatal membranes, in order to measure its intrinsic affinity for the dopamine (DA) receptor;NT=Not Tested";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2093868";"Dopamine receptor";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"21.36";"0.40";"6.19";"9.14";"0";"CHEMBL4805249";"Inhibition of CDK8 in TNF-alpha-induced CDK8 and CDK19-knockout HEK293 cells by NF-kappaB reporter assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5719";"Cell division protein kinase 8";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804282";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"";"INHIBITOR";"";"3.4"
"CHEMBL160340";"";"None";"542.71";"0";"4.15";"6";"CCCc1ccc(Oc2cccc(CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-])c2)cc1.[K+].[K+].[K+]";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL941164";"Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus Pig1 isolate after 72 hrs";"F";"BAO_0000218";"organism-based format";"Staphylococcus aureus";"None";"None";"None";"None";"";"";"";"CHEMBL352";"Staphylococcus aureus";"Staphylococcus aureus";"ORGANISM";"CHEMBL1140905";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";"";"0.093"
"CHEMBL3827679";"";"None";"551.45";"0";"1.74";"1";"Cl.Cl.N=C(N)N/N=C/c1c(-c2ccccc2)nc2n1ccc1nc(-c3ccccc3)c(/C=N/NC(=N)N)n12";"IC50";"'='";"15970.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3831001";"Cytotoxicity against human U2OS cells assessed as cell killing after 24 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL615023";"U2OS";"Homo sapiens";"CELL-LINE";"CHEMBL3826876";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307757";"";"";"";"15.97"
"CHEMBL448332";"LUIDIAQUINOSIDE";"None";"1281.40";"None";"None";"1, Luidiaquinoside";"CC(C)CC(=O)C[C@](C)(O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](C)[C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](C)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O[C@@H]5O[C@H](C)[C@@H](O)[C@H](O)[C@H]5O)[C@H]4O)[C@H]4C[C@@H](OS(=O)(=O)[O-])CC[C@]4(C)C3=CC[C@@]21C.[Na+]";"IC50";"'='";"31.3";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL991215";"Cytotoxicity against rat RBL2H3 after 24 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Rattus norvegicus";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL614632";"RBL-2H3";"Rattus norvegicus";"CELL-LINE";"CHEMBL1159360";"1";"Scientific Literature";"J Nat Prod";"2003";"CHEMBL3307666";"";"";"";"31.3"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"950.0";"nM";"6.02";"";"";"UO_0000065";"13.46";"0.26";"2.72";"7.94";"0";"CHEMBL3992002";"Inhibition of cKIT D816V mutant (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"P10721";"D816V";"CHEMBL1936";"Stem cell growth factor receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"None";"";"";"";"0.95"
"CHEMBL4103870";"";"None";"363.44";"1";"5.43";"12f";"O=C(c1ccc([N+](=O)[O-])cc1)c1c(-c2ccccc2)sc2c1CCCC2";"IC50";"'='";"28120.0";"nM";"4.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3994725";"Antiproliferative activity against human Caco2 cells after 48 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Caco-2";"None";"";"";"";"CHEMBL614058";"Caco-2";"Homo sapiens";"CELL-LINE";"CHEMBL3994563";"1";"Scientific Literature";"Medchemcomm";"2016";"CHEMBL3307519";"";"";"";"28.12"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL4738662";"Inhibition of recombinant CDK1 (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated Histone H1 peptide as substrate incubated for 1 hr in presence of [33P]ATP by liquid scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732230";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.003"
"CHEMBL2103881";"DEXMECAMYLAMINE";"3.0";"167.30";"0";"2.42";"13, TC-5214";"CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"37.19";"0.71";"3.80";"51.72";"0";"CHEMBL3363160";"Antagonist activity at human alpha1beta1gammadelta nAChR";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907588";"Acetylcholine receptor; alpha1/beta1/delta/gamma";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3352239";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"0.6"
"CHEMBL2103881";"DEXMECAMYLAMINE";"3.0";"167.30";"0";"2.42";"13, TC-5214";"CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"40.04";"0.76";"4.28";"55.69";"0";"CHEMBL3363158";"Antagonist activity at human alpha3beta4 nAChR";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907594";"Neuronal acetylcholine receptor; alpha3/beta4";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3352239";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"0.2"
"CHEMBL2103886";"RESCIMETOL";"2.0";"590.67";"1";"4.26";"SID170465875";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2ccc(O)c(OC)c2)[C@@H]1OC";"IC50";"";"20000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3561978";"PubChem BioAssay. nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"C2C12";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"CHEMBL3308003";"";"";"";"20.0"
"CHEMBL1203470";"";"None";"411.96";"1";"5.04";"135";"Cc1[nH]c2ccccc2c1-c1nc(NC(=N)NCc2ccccc2)sc1C.Cl";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"14.05";"0.27";"0.24";"6.89";"0";"CHEMBL689041";"Inhibitory activity of gastric proton-pump enzyme H+/K+ ATPase was determined at 50 uM";"B";"BAO_0000221";"tissue-based format";"Canis lupus familiaris";"CHEMBL3638185";"Stomach";"None";"None";"";"";"";"CHEMBL2095173";"Potassium-transporting ATPase";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL1125091";"1";"Scientific Literature";"J Med Chem";"1990";"None";"";"";"";"5.3"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836766";"Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs by filter binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"UNDEFINED MUTATION";"CHEMBL1974";"Tyrosine-protein kinase receptor FLT3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834472";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.333 hr";"";"";"2.0"
"CHEMBL2103841";"CANAGLIFLOZIN";"None";"907.06";"0";"2.97";"1";"Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.O";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"19.48";"0.38";"5.69";"9.60";"0";"CHEMBL2415852";"Inhibition of human SGLT2 expressed in CHOK cells assessed as reduction of [14C]alpha-methyl-D-glucopyranoside uptake after 120 mins by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHOK";"None";"";"";"";"CHEMBL3884";"Sodium/glucose cotransporter 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2413069";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";"";"2.2"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL3877183";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875233";"1";"Scientific Literature";"Nat Rev Drug Discov";"2017";"None";"";"";"";"3.0"
"CHEMBL2018370";"";"None";"479.54";"0";"3.49";"3a";"CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.31";"0.33";"4.81";"9.18";"1";"CHEMBL3579778";"Inhibition of [125I]hMCP1 binding to CCR2 in human PBMC incubated for 30 mins at room temperature";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4015";"C-C chemokine receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576800";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"5.0"
"CHEMBL2103852";"CROLIBULIN";"2.0";"417.26";"0";"2.85";"Crolibulin";"COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4147473";"Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SMMC-7721";"None";"";"";"";"CHEMBL613831";"SMMC-7721";"Homo sapiens";"CELL-LINE";"CHEMBL4145506";"1";"Scientific Literature";"Eur J Med Chem";"2018";"CHEMBL3308059";"";"";"";""
"CHEMBL1223870";"";"None";"442.60";"0";"3.38";"trans-10";"CN(C)C(=O)N[C@H]1CC[C@H](CCN2[C@@H]3CC[C@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1225863";"Antagonist activity at human delta opioid receptor expressed in HEK cells assessed as inhibition of SNC-80-induced [35S]GTPgammaS binding";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL236";"Delta opioid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221377";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3307715";"";"";"";"30000.0"
"CHEMBL213870";"";"None";"430.91";"0";"4.80";"22b";"COc1cc(NS(=O)(=O)c2ccc3c(c2)c2ccccc2n3C)c(OC)cc1Cl";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL855552";"Antiproliferative activity against human CEM cells after 72 hrs";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FaDu";"None";"";"";"";"CHEMBL612250";"FaDu";"Homo sapiens";"CELL-LINE";"CHEMBL1137382";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307943";"";"";"";"46.0"
"CHEMBL1210870";"";"None";"408.51";"0";"2.29";"24";"c1ccc2c(CCNc3nc(N4CCOCC4)cc(N4CCOCC4)n3)c[nH]c2c1";"IC50";"'='";"3.05";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1211078";"Antileishmanial activity against amastigote of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay";"F";"BAO_0000218";"organism-based format";"Leishmania donovani";"None";"None";"J774.A1";"None";"";"";"";"CHEMBL367";"Leishmania donovani";"Leishmania donovani";"ORGANISM";"CHEMBL1208669";"1";"Scientific Literature";"Eur J Med Chem";"2010";"CHEMBL3307516";"";"";"";"3.05"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992014";"Cytotoxic activity in human A549 cells expressing Rad51";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3307651";"";"";"";"6.9"
"CHEMBL203170";"";"None";"845.96";"2";"-1.14";"7";"CCCC[C@@H]1NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL867662";"Inhibitory activity against hMC5R transfected in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4608";"Melanocortin receptor 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138987";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307715";"";"";"";"10000.0"
"CHEMBL2203870";"AZEPINOMYCIN";"None";"168.16";"0";"-1.12";"1, enantiomeric mixture";"O=C1NC(O)CNc2nc[nH]c21";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"31.52";"0.60";"6.42";"5.89";"0";"CHEMBL2213713";"Inhibition of guanase";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3129";"Guanine deaminase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2202998";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"5.0"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"66300.0";"nM";"4.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992018";"Potentiation of carboplatin induced DNA damage in human NCI-H647 cells expressing Rad51 assessed as carboplatin IC50 at 0.79 uM (Rvb IC50 = 172.53 uM)";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H647";"None";"";"";"";"CHEMBL614999";"NCI-H647";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3308691";"";"";"";"66.3"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"21.05";"0.39";"6.07";"9.01";"0";"CHEMBL4805248";"Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5719";"Cell division protein kinase 8";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804282";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"";"INHIBITOR";"";"4.5"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4403340";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402527";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"1.0"
"CHEMBL1223870";"";"None";"442.60";"0";"3.38";"trans-10";"CN(C)C(=O)N[C@H]1CC[C@H](CCN2[C@@H]3CC[C@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)CC1";"IC50";"'='";"18862.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1225862";"Antagonist activity at human mu opioid receptor expressed in HEK cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL233";"Mu opioid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221377";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3307715";"";"";"";"18862.0"
"CHEMBL2103852";"CROLIBULIN";"2.0";"417.26";"0";"2.85";"Crolibulin";"COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147470";"Antiproliferative activity against human H460 cells after 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H460";"None";"";"";"";"CHEMBL396";"NCI-H460";"Homo sapiens";"CELL-LINE";"CHEMBL4145506";"1";"Scientific Literature";"Eur J Med Chem";"2018";"CHEMBL3307677";"";"";"";"0.03"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445907";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line T84, K-Ras mutation)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T84";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307275";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"36.0"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"88.19";"nM";"7.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5151306";"Cytotoxicity against human MES-SA/Dx5 cells assessed as inhibition in cell growth";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MES-SA/Dx5";"None";"";"";"";"CHEMBL613827";"MES-SA/Dx5";"Homo sapiens";"CELL-LINE";"CHEMBL5149986";"1";"Scientific Literature";"J Nat Prod";"2021";"CHEMBL3308373";"";"";"";"88.19"
"CHEMBL2011870";"";"None";"302.40";"0";"3.72";"14";"COc1ccc(-c2nsc(NC(=O)[C@@H]3C[C@H]3C)c2C)cc1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2016180";"Allosteric antagonist activity at human recombinant mGluR1 expressed in AV12 cells assessed as intracellular calcium concentration using Fluo-3 dye by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"AV12";"None";"";"";"";"CHEMBL3772";"Metabotropic glutamate receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"32.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"7.512";"nM";"8.12";"";"";"UO_0000065";"20.49";"0.38";"5.84";"8.77";"0";"CHEMBL5353309";"Inhibition of human full length CDK2/CyclinA2 by ADP-Glo kinase assay";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3038469";"CDK2/Cyclin A2";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5352406";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"7.512"
"CHEMBL210870";"";"None";"268.65";"0";"1.53";"10";"O=C(CC(=O)C(=O)O)CC(=O)c1cccc(Cl)c1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"18.97";"0.39";"3.57";"5.76";"0";"CHEMBL871193";"Inhibition of HIV1 recombinant integrase";"B";"BAO_0000357";"single protein format";"Human immunodeficiency virus 1";"None";"None";"None";"None";"";"";"";"CHEMBL3471";"Human immunodeficiency virus type 1 integrase";"Human immunodeficiency virus 1";"SINGLE PROTEIN";"CHEMBL1147712";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";"";"8.0"
"CHEMBL1203860";"";"None";"503.46";"1";"5.87";"63";"Cl.Cl.Fc1ccc(C2CC(N3CCN(C/C=C/c4ccccc4)CC3)c3cc(F)ccc32)cc1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL816027";"Ability to displace [3H]haloperidol from rat striatal membranes, in order to measure its intrinsic affinity for the dopamine (DA) receptor;NT=Not Tested";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2093868";"Dopamine receptor";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";""
"CHEMBL2103855";"TELOTRISTAT";"4.0";"546.94";"1";"4.51";"LX 1033";"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"14.25";"0.28";"3.29";"5.48";"0";"CHEMBL3769268";"Inhibition of TPH1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5689";"Tryptophan 5-hydroxylase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763113";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"16.0"
"CHEMBL1203873";"";"None";"444.35";"0";"2.64";"78";"Cl.Cl.NC(=O)CN1CCN(C2CC(c3ccc(F)cc3)c3ccc(F)cc32)CC1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL816027";"Ability to displace [3H]haloperidol from rat striatal membranes, in order to measure its intrinsic affinity for the dopamine (DA) receptor;NT=Not Tested";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2093868";"Dopamine receptor";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"12";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4701384";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699469";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"1";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350555";"Inhibition of human ERG channel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL240";"HERG";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346624";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"1.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445909";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line COLO205, B-Raf mutation)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"COLO 205";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3308348";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"0.52"
"CHEMBL2011870";"";"None";"302.40";"0";"3.72";"5";"COc1ccc(-c2nsc(NC(=O)[C@@H]3C[C@H]3C)c2C)cc1";"IC50";"'='";"158.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2344546";"Negative allosteric modulation of human recombinant mGlu5 receptor expressed in Syrian hamster AV12 cells assessed as receptor-mediated changes in intracellular calcium concentration by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"AV12";"None";"";"";"";"CHEMBL3227";"Metabotropic glutamate receptor 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2331451";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"158.0"
"CHEMBL1223870";"";"None";"442.60";"0";"3.38";"trans-10";"CN(C)C(=O)N[C@H]1CC[C@H](CCN2[C@@H]3CC[C@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)CC1";"IC50";"'='";"451.0";"nM";"6.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1225861";"Antagonist activity at human kappa opioid receptor expressed in HEK cells assessed as inhibition of dynorphin A-induced [35S]GTPgammaS binding";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL237";"Kappa opioid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221377";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3307715";"";"";"";"451.0"
"CHEMBL2011870";"";"None";"302.40";"0";"3.72";"14";"COc1ccc(-c2nsc(NC(=O)[C@@H]3C[C@H]3C)c2C)cc1";"IC50";"'='";"158.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2016181";"Antagonist activity at human mGluR5";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3227";"Metabotropic glutamate receptor 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"158.0"
"CHEMBL2010870";"";"None";"463.55";"0";"4.65";"11c";"CC(C)n1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2015674";"Inhibition of human VEGFR2 expressed in porcine PAE145 cells cotransfected with chimeric rat TRK-A/KDR receptor after 1 hr by immunofluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL279";"Vascular endothelial growth factor receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010689";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"10.0"
"CHEMBL2010870";"";"None";"463.55";"0";"4.65";"11c";"CC(C)n1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"15.36";"0.28";"2.47";"7.94";"0";"CHEMBL2015673";"Inhibition of human recombinant Tie2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4128";"Tyrosine-protein kinase TIE-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010689";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"76.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445906";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line SW620, K-Ras mutation)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW-620";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307944";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"2.3"
"CHEMBL103870";"";"None";"443.96";"0";"4.04";"49";"COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(Cl)cc4)CC3)c2cc1OC";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL846117";"Inhibition of PDGF-BB-induced proliferation of porcine aorta smooth muscle cells";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"PASMC";"None";"";"";"";"CHEMBL613548";"PASMC";"Sus scrofa";"CELL-LINE";"CHEMBL1135502";"1";"Scientific Literature";"J Med Chem";"2002";"CHEMBL3308042";"";"";"";"0.24"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5352092";"Cytotoxicity against human HepG2 cells incubated for 72 hrs measured by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HepG2";"None";"";"";"";"CHEMBL395";"HepG2";"Homo sapiens";"CELL-LINE";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"CHEMBL3307718";"TIME = 72.0 hr";"";"";"0.21"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"10.1";"nM";"8.00";"";"";"UO_0000065";"20.12";"0.38";"5.58";"7.69";"0";"CHEMBL5352096";"Inhibition of HDAC3 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1829";"Histone deacetylase 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"10.1"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"Tafamidis";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"9300.0";"nM";"5.03";"";"";"UO_0000065";"16.33";"0.34";"0.53";"7.94";"0";"CHEMBL5144851";"Inhibition of urea-induced Transthyretin denaturation in human plasma preincubated for 1 hr followed by urea addition by Western blot analysis";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"None";"Plasma";"None";"None";"";"";"";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143546";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"9.3"
"CHEMBL1203807";"";"None";"395.33";"0";"2.83";"20";"Cc1ccc(-c2nc3c(C(=O)NCCN(C)C)cccc3[nH]2)cc1.Cl.Cl";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL754894";"In vitro cell growth inhibitory activity against wild type P388 murine leukemia cell line (P388/W)";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"P388";"None";"";"";"";"CHEMBL389";"P388";"Mus musculus";"CELL-LINE";"CHEMBL1125099";"1";"Scientific Literature";"J Med Chem";"1990";"CHEMBL3308401";"";"";"";"7.8"
"CHEMBL2103777";"THIOPHANATE";"-1.0";"370.46";"0";"2.57";"Thiophanate";"CCOC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OCC";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1262114";"Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian hepatocytes after 48 hrs";"F";"BAO_0000218";"organism-based format";"Plasmodium yoelii yoelii";"None";"None";"Hepatocyte";"None";"";"";"";"CHEMBL612328";"Plasmodium yoelii yoelii";"Plasmodium yoelii yoelii";"ORGANISM";"CHEMBL1255292";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308022";"";"";"";"3.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445915";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line SW620, K-Ras mutation)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW-620";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307944";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"2.3"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL5353308";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352406";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"4.0"
"CHEMBL2105699";"ATOPAXAR HYDROBROMIDE";"2.0";"608.55";"1";"4.79";"Example 1";"Br.CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"14.38";"0.27";"2.80";"9.00";"0";"CHEMBL3880487";"Displacement of [3H] Ala-(4fluoro)Phe-Arg-(cy- clohexyl)Ala-(homo)Arg-Tyr-NH2 from thrombin receptor in human platelet membranes after 1 hr by liquid scintillation counting method";"B";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3974";"Proteinase-activated receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3880385";"38";"SureChEMBL Patent Bioactivity Data";"";"2011";"None";"";"";"";"0.026"
"CHEMBL2104850";"RILAPINE";"2.0";"361.88";"0";"4.35";"COVC-2286540340";"CN1CCN(C2=Cc3cc(Cl)ccc3/C(=C/C#N)c3ccccc32)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"8, STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"20.01";"0.37";"4.04";"7.59";"0";"CHEMBL2424065";"Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from recombinant human Trap-1 after 24 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1075132";"Heat shock protein 75 kDa, mitochondrial";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417440";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"51.0"
"CHEMBL1213870";"THIOLACTOMYCIN 8";"None";"338.43";"0";"4.32";"SI, thiolactomycin8";"CC1=C(O)[C@@](C)(Cc2cccc(C(=O)c3ccccc3)c2)SC1=O";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217000";"Antimicrobial activity against Plasmodium falciparum";"F";"BAO_0000218";"organism-based format";"Plasmodium falciparum";"None";"None";"None";"None";"";"";"";"CHEMBL364";"Plasmodium falciparum";"Plasmodium falciparum";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"16.0"
"CHEMBL203170";"";"None";"845.96";"2";"-1.14";"7";"CCCC[C@@H]1NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC1=O";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"8.07";"0.15";"7.96";"2.04";"0";"CHEMBL867660";"Inhibitory activity against hMC4R transfected in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL259";"Melanocortin receptor 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138987";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307715";"";"";"";"150.0"
"CHEMBL1203830";"";"None";"382.30";"0";"1.92";"23";"CN(C)CCNC(=O)c1cccc2[nH]c(-c3ccncc3)nc12.Cl.Cl";"IC50";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL754894";"In vitro cell growth inhibitory activity against wild type P388 murine leukemia cell line (P388/W)";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"P388";"None";"";"";"";"CHEMBL389";"P388";"Mus musculus";"CELL-LINE";"CHEMBL1125099";"1";"Scientific Literature";"J Med Chem";"1990";"CHEMBL3308401";"";"";"";"6.6"
"CHEMBL2105699";"ATOPAXAR HYDROBROMIDE";"2.0";"608.55";"1";"4.79";"Example 1";"Br.CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880488";"Antiproliferative activity against thrombin-induced vesicular smooth muscle cells isolated from Sprague-Dawley rat aorta after 2 days by MTT assay";"F";"BAO_0000019";"assay format";"Rattus norvegicus";"None";"None";"VSMC";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880385";"38";"SureChEMBL Patent Bioactivity Data";"";"2011";"CHEMBL4295516";"";"";"";"0.032"
"CHEMBL1210380";"";"None";"353.45";"0";"4.88";"10c";"O=C(O)c1sc(-c2ccccc2)cc1-c1cnnn1C1CCCCC1";"IC50";"'='";"0.34";"nM";"9.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1212365";"Inhibition of HCV GT1b NS5B polymerase";"B";"BAO_0000019";"assay format";"Hepatitis C virus";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1208715";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.34"
"CHEMBL2403870";"";"None";"438.41";"1";"5.51";"6";"Cc1ccc2c(c1)nc(C)n2[C@H]1CC[C@@H](NC[C@H]2Cc3ccc(Br)cc3C2)C1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"15.14";"0.32";"1.13";"22.24";"0";"CHEMBL2406561";"Displacement of [125I]MCH peptide from human MCHR1 expressed in CHOK1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL344";"Melanin-concentrating hormone receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401722";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307512";"";"";"";"0.23"
"CHEMBL2036870";"";"None";"317.35";"0";"3.48";"2h";"Cn1c(-c2ccnc(Nc3cccc(O)c3)n2)nc2ccccc21";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2038022";"Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4282";"Serine/threonine-protein kinase AKT";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034932";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";"";"100.0"
"CHEMBL2103851";"AMUVATINIB";"2.0";"447.52";"0";"3.30";"HPK56; III-1-3";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.34";"0.24";"2.22";"7.28";"0";"CHEMBL3882685";"Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PANC-1";"None";"";"";"";"CHEMBL2007";"Platelet-derived growth factor receptor alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882391";"38";"SureChEMBL Patent Bioactivity Data";"";"2008";"CHEMBL3307545";"";"";"";"3.0"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992015";"Potentiation of carboplatin induced DNA damage in human A549 cells expressing Rad51 assessed as carboplatin IC50 at 0.71 uM (Rvb IC50 = 20.14 uM)";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3307651";"";"";"";"6.3"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"Tafamidis";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"17.88";"0.38";"1.01";"8.70";"0";"CHEMBL3862350";"Stabilization of recombinant human wild type TTR expressed in Escherichia coli BL21 (DE3) assessed as inhibition of amyloid beta formation by measuring turbidity preincubated for 30 mins followed by lowering pH from 7.2 to 4.4 measured after 72 hrs by microplate spectrophotometric method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3861954";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"3.1"
"CHEMBL1223870";"";"None";"442.60";"0";"3.38";"trans-10";"CN(C)C(=O)N[C@H]1CC[C@H](CCN2[C@@H]3CC[C@H]2C[C@@H](Oc2cccc(C(N)=O)c2)C3)CC1";"IC50";"'>'";"33000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1225864";"Inhibition of human ERG by electrophysiology assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL240";"HERG";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221377";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"33.0"
"CHEMBL2103881";"DEXMECAMYLAMINE";"3.0";"167.30";"0";"2.42";"13, TC-5214";"CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"37.66";"0.72";"3.88";"52.38";"0";"CHEMBL3363157";"Antagonist activity at human alpha4beta2 nAChR";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907589";"Neuronal acetylcholine receptor; alpha4/beta2";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3352239";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"0.5"
"CHEMBL2103886";"RESCIMETOL";"2.0";"590.67";"1";"4.26";"SID170465875";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2ccc(O)c(OC)c2)[C@@H]1OC";"IC50";"";"10000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3561991";"PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"CHEMBL3308376";"";"";"";"10.0"
"CHEMBL2018370";"";"None";"479.54";"0";"3.49";"7b";"CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2019387";"Antagonist activity at CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4015";"C-C chemokine receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016523";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"240.0"
"CHEMBL2103886";"RESCIMETOL";"2.0";"590.67";"1";"4.26";"SID170465875";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2ccc(O)c(OC)c2)[C@@H]1OC";"IC50";"'='";"10446.1";"nM";"4.98";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3562121";"PubChem BioAssay. alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"C2C12";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"CHEMBL3308003";"";"";"";"10.4461"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992008";"Cytotoxicity against human OVCAR3 cells assessed as reduction in cell proliferation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"OVCAR-3";"None";"";"";"";"CHEMBL614213";"OVCAR-3";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3307564";"";"";"";"0.9"
"CHEMBL3577957";"";"None";"365.91";"0";"1.44";"11j";"Cl.O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CC2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3578413";"Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL240";"HERG";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576859";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307715";"";"";"";"10.0"
"CHEMBL2010870";"";"None";"463.55";"0";"4.65";"11c";"CC(C)n1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.39";"0.33";"3.87";"9.51";"0";"CHEMBL2015672";"Inhibition of human recombinant VEGF-R2 expressed in baculovirus expression system using GST-PLCgamma as substrate after 1 hr by time-resolved fluorescence analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL279";"Vascular endothelial growth factor receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010689";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"3.0"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"15.85";"0.30";"3.79";"9.34";"0";"CHEMBL3992006";"Inhibition of PDGFRalpha D842V mutant (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"P16234";"D842V";"CHEMBL2007";"Platelet-derived growth factor receptor alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"None";"";"";"";"0.081"
"CHEMBL2018870";"";"None";"580.71";"1";"4.71";"16";"COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2019580";"Antagonist activity at rat bradykinin B1 receptor";"F";"BAO_0000019";"assay format";"Rattus norvegicus";"None";"None";"None";"None";"";"";"";"CHEMBL4613";"Bradykinin B1 receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL2016470";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"81.0"
"CHEMBL1203860";"";"None";"503.46";"1";"5.87";"64";"Cl.Cl.Fc1ccc(C2CC(N3CCN(C/C=C/c4ccccc4)CC3)c3cc(F)ccc32)cc1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL670185";"Effect on synaptosomal uptake inhibition of Dopamine transporter";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL338";"Dopamine transporter";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";"210.0"
"CHEMBL2003873";"";"None";"366.87";"0";"4.93";"SID17411380";"O=C(N/N=C/c1ccc(Cl)cc1)c1cc2c(s1)-c1ccccc1CC2";"IC50";"'='";"19993.0";"nM";"4.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1794574";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493091, AID493120]";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1795098";"Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"19.993"
"CHEMBL2013070";"";"None";"410.47";"1";"5.01";"7";"COCOc1c(OCOC)c(-c2ccc(O)cc2)c(C)c(C)c1-c1ccc(O)cc1";"IC50";"'='";"0.32";"nM";"9.49";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2014888";"Antiinflammatory activity in rat RBL2H3 cells assessed as inhibition of DNP-BSA-induced TNF-alpha production preincubated for 15 mins prior DNP-BSA challenge measured after 30 mins by ELISA";"F";"BAO_0000219";"cell-based format";"Rattus norvegicus";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL614632";"RBL-2H3";"Rattus norvegicus";"CELL-LINE";"CHEMBL2010773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307666";"";"";"";"0.32"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.096";"nM";"10.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5151310";"Cytotoxicity against human MES-SA cells assessed as inhibition in cell growth";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MES-SA";"None";"";"";"";"CHEMBL614343";"MES-SA";"Homo sapiens";"CELL-LINE";"CHEMBL5149986";"1";"Scientific Literature";"J Nat Prod";"2021";"CHEMBL3307599";"";"";"";"0.096"
"CHEMBL2036870";"";"None";"317.35";"0";"3.48";"2h";"Cn1c(-c2ccnc(Nc3cccc(O)c3)n2)nc2ccccc21";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"17.12";"0.31";"1.95";"7.16";"0";"CHEMBL2038026";"Inhibition of recombinant PLK1 using RBERCHKtide as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3024";"Serine/threonine-protein kinase PLK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034932";"1";"Scientific Literature";"Eur J Med Chem";"2012";"None";"";"";"";"3.7"
"CHEMBL2017870";"";"None";"394.91";"0";"4.08";"16c";"CN(C)[C@@H]1CCN(c2cc(Nc3cc(Cl)ccn3)nc(-c3ccccc3)n2)C1";"IC50";"'='";"176.0";"nM";"6.75";"";"";"UO_0000065";"17.10";"0.33";"2.67";"11.81";"0";"CHEMBL2020901";"Inhibition of Mycobacterium tuberculosis GST-fused PknB expressed in Escherichia coli assessed as GarA substrate phosphorylation after 30 mins";"B";"BAO_0000019";"assay format";"Mycobacterium tuberculosis";"None";"None";"None";"None";"";"";"";"CHEMBL1908385";"Serine/threonine-protein kinase pknB";"Mycobacterium tuberculosis";"SINGLE PROTEIN";"CHEMBL2016574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"0.176"
"CHEMBL413870";"";"None";"1491.73";"None";"None";"XXIX";"CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C(C)C)NC1=O";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833507";"Inhibitory concentration for human complement component C3 activation";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4917";"Complement C3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139489";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";"";"1000.0"
"CHEMBL3989516";"FOSTAMATINIB DISODIUM";"4.0";"732.52";"2";"3.09";"1";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)([O-])[O-])C(=O)C(C)(C)O4)n2)cc(OC)c1OC.O.O.O.O.O.O.[Na+].[Na+]";"IC50";"'='";"267.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2189056";"Cytotoxicity against human Ramos cells";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL614629";"Ramos";"Homo sapiens";"CELL-LINE";"CHEMBL2176924";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307664";"";"";"";"0.267"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"95.1";"nM";"7.02";"";"370426";"UO_0000065";"20.81";"0.42";"5.57";"7.72";"1";"CHEMBL3888065";"JAK Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3 and 60 minutes for Tyk-2.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2148";"Tyrosine-protein kinase JAK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886558";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"95.1"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"17.88";"0.34";"4.70";"10.54";"0";"CHEMBL3992001";"Inhibition of cKIT D816H mutant (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"P10721";"D816H";"CHEMBL1936";"Stem cell growth factor receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"None";"";"";"";"0.01"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"16.69";"0.32";"4.17";"9.84";"0";"CHEMBL3992003";"Inhibition of cKIT V560G mutant (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"P10721";"V560G";"CHEMBL1936";"Stem cell growth factor receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"None";"";"";"";"0.034"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"8047.0";"nM";"5.09";"";"";"UO_0000065";"11.38";"0.22";"1.79";"6.71";"0";"CHEMBL3992005";"Inhibition of Flt3 D835Y mutant (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"P36888";"D835Y";"CHEMBL1974";"Tyrosine-protein kinase receptor FLT3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"None";"";"";"";"8.047"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"27030.0";"nM";"4.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992019";"Potentiation of carboplatin induced DNA damage in human NCI-H647 cells expressing Rad51 assessed as carboplatin IC50 at 2 uM (Rvb IC50 = 172.53 uM)";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H647";"None";"";"";"";"CHEMBL614999";"NCI-H647";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3308691";"";"";"";"27.03"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"0";"CHEMBL4836765";"Inhibition of CDK2/Cyclin A1 (unknown origin) at 1 uM using histone H1 as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs by filter binding method";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3038470";"CDK2/Cyclin A1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4834472";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Dose = 1.0 microM | TIME = 2.333 hr";"INHIBITOR";"";"0.003"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"COVC-1745773454";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL4124402";"Inhibition of CDK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate after 1 hr by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118232";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"11; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"0";"CHEMBL3856488";"Inhibition of recombinant CDK5/p25 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated histone H1 as substrate after 1 hr by gamma32P-ATP based liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1907600";"Cyclin-dependent kinase 5/CDK5 activator 1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3856187";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308860";"";"";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836768";"Antiproliferative activity against human MV4-11 cells assessed as cell death measured after 72 hrs by resazurin dye based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MV4-11";"None";"";"";"";"CHEMBL613835";"MV4-11";"Homo sapiens";"CELL-LINE";"CHEMBL4834472";"1";"Scientific Literature";"J Med Chem";"2021";"CHEMBL3308063";"TIME = 72.0 hr";"";"";"0.006999999999999999"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880496";"Growth inhibition of human KM12 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KM12";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307689";"";"";"";"0.023"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880499";"Growth inhibition of human COLO205 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"COLO 205";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308348";"";"";"";"0.001"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"12";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4701386";"Inhibition of CDK5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699469";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2018370";"";"None";"479.54";"0";"3.49";"3a";"CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"13.80";"0.27";"3.13";"7.32";"1";"CHEMBL3579779";"Antagonist activity against CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis at 37 degC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4015";"C-C chemokine receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576800";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"240.0"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"COVC-2283593047";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"COVC-1745773454";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2105695";"TELOTRISTAT ETHYL";"4.0";"574.99";"1";"4.99";"COVC-1746072585";"CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103847";"TOSEDOSTAT";"2.0";"406.48";"0";"1.86";"CHR 2797";"CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.33";"0.27";"3.96";"4.66";"0";"CHEMBL4407172";"Inhibition of MMP9 (unknown origin) using QF-24 as substrate preincubated for 1 hr followed by substrate addition and measured at 1 min interval for 1 hr by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL321";"Matrix metalloproteinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406801";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"1.5"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"1";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'='";"267.0";"nM";"6.57";"";"";"UO_0000065";"11.32";"0.22";"3.48";"3.52";"0";"CHEMBL2350851";"Inhibition of SYK in human Ramos cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL2599";"Tyrosine-protein kinase SYK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346624";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307664";"";"";"";"0.267"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880513";"Growth inhibition of human HOP62 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HOP-62";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307671";"";"";"";"1.0"
"CHEMBL4103870";"";"None";"363.44";"1";"5.43";"12f";"O=C(c1ccc([N+](=O)[O-])cc1)c1c(-c2ccccc2)sc2c1CCCC2";"IC50";"'='";"13200.0";"nM";"4.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3994724";"Antiproliferative activity against human MIAPaCa2 cells after 48 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MIA PaCa-2";"None";"";"";"";"CHEMBL614725";"MIA PaCa-2";"Homo sapiens";"CELL-LINE";"CHEMBL3994563";"1";"Scientific Literature";"Medchemcomm";"2016";"CHEMBL3308500";"";"";"";"13.2"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"1980.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992024";"Potentiation of etoposide induced DNA damage in human DMS114 cells expressing Rad51 assessed as etoposide IC50 at 0.1 uM (Rvb IC50 = 0.92 uM)";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DMS-114";"None";"";"";"";"CHEMBL614642";"DMS-114";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3307670";"";"";"";"1.98"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"Tafamidis";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"3090.3";"nM";"5.51";"";"";"UO_0000065";"17.88";"0.38";"1.01";"8.70";"0";"CHEMBL3862350";"Stabilization of recombinant human wild type TTR expressed in Escherichia coli BL21 (DE3) assessed as inhibition of amyloid beta formation by measuring turbidity preincubated for 30 mins followed by lowering pH from 7.2 to 4.4 measured after 72 hrs by microplate spectrophotometric method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3861954";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"5.51"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909138";"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BTI-TN-5B1-4";"None";"";"";"";"CHEMBL340";"Cytochrome P450 3A4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833782";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909160";"DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3559723";"Liver";"None";"Membrane";"";"";"";"CHEMBL5486";"Insulin receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4841251";"Inhibition of CDK5 (unknown origin) expressed in Sf9 insect cells using biotinylated peptide derived Histone H1 as substrate incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840335";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1.0"
"CHEMBL2103851";"AMUVATINIB";"2.0";"447.52";"0";"3.30";"AMUVATINIB";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"0.02  0";"UO_0000065";"";"";"";"";"0";"CHEMBL4303806";"Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells after 48 hours by high content imaging";"F";"BAO_0000218";"organism-based format";"Homo sapiens";"None";"None";"Caco-2";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4303101";"52";"SARS-CoV-2 Screening Data";"";"2020";"CHEMBL3307519";"";"";"";"0.02"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909086";"DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3559723";"Liver";"None";"Membrane";"";"";"";"CHEMBL315";"Alpha-1b adrenergic receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909131";"DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf21";"None";"";"";"";"CHEMBL230";"Cyclooxygenase-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL4106362";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909193";"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)";"B";"BAO_0000357";"single protein format";"Escherichia coli";"None";"None";"None";"None";"";"";"";"CHEMBL4801";"Caspase-1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.79";"nM";"9.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5152795";"Cytotoxicity against human LNCaP cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter-96 assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LNCaP";"None";"";"";"";"CHEMBL612518";"LNCaP";"Homo sapiens";"CELL-LINE";"CHEMBL5150030";"1";"Scientific Literature";"J Med Chem";"2022";"CHEMBL3307965";"TIME = 72.0 hr";"";"";"0.79"
"CHEMBL2103849";"UDENAFIL";"3.0";"516.67";"1";"2.83";"DA-8159; 15";"CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1";"IC50";"'='";"8.25";"nM";"8.08";"";"";"UO_0000065";"15.65";"0.31";"5.25";"6.61";"0";"CHEMBL5153400";"Inhibition of PDE5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1827";"Phosphodiesterase 5A";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150054";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";"";"8.25"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445901";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line COLO320 DM, WT)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"COLO 320";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307577";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"10000.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445904";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line LS-174T, K-Ras mutation)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LS174T";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307536";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"4.1"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909114";"DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL2327";"Neurokinin 2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";"";"";"";""
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"0.48";"nM";"9.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445898";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in HT-29 cells, B-Raf mutation)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HT-29";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307768";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"0.48"
"CHEMBL2103773";"OTILONIUM BROMIDE";"3.0";"563.58";"1";"6.32";"SID170466098";"CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1.[Br-]";"IC50";"'='";"8465.81";"nM";"5.07";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3562024";"PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) ";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"8.46581"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909204";"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Insect cells";"None";"";"";"";"CHEMBL1841";"Tyrosine-protein kinase FYN";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909180";"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL236";"Delta opioid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909196";"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Rheumatoid synovial fibroblasts";"None";"None";"";"";"";"CHEMBL332";"Matrix metalloproteinase-1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2379854";"Cytotoxicity against human MCF7 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL387";"MCF7";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308403";"";"";"";"0.02"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.94";"0.41";"6.42";"9.39";"0";"CHEMBL3777409";"Inhibition of CDK2/Cyclin E (unknown origin) expressed in sf9 cells using histone H1 as substrate in presence of [gamma33P]-ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1907605";"Cyclin-dependent kinase 2/cyclin E1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3774312";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308860";"";"";"";"0.002"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880506";"Growth inhibition of human NCI-H1355 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H1355";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308876";"";"";"";"0.052"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880507";"Growth inhibition of human NCI-H1792 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H1792";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308816";"";"";"";"0.053"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880523";"Growth inhibition of human NCI-H508 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H508";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL4632323";"";"";"";"0.008"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880546";"Growth inhibition of human HCC827 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCC827";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL4295384";"";"";"";"0.04"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909084";"DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine)";"B";"BAO_0000249";"cell membrane format";"Cavia porcellus";"CHEMBL3559724";"Cerebral cortex";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL5343379";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338803";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"4.0"
"CHEMBL2103856";"ATOPAXAR";"2.0";"527.64";"1";"4.79";"Atopaxar";"CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4224007";"Antagonist activity at PAR1 in human EAhy926 cells assessed as inhibition of TFLLRN-NH2-induced intracellular calcium mobilization pretreated for 15 mins followed by TFLLRN-NH2 addition measured at 5 secs interval for 250 secs by Fluo-4/AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3974";"Proteinase-activated receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219243";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"7.5"
"CHEMBL2103872";"CEFTOLOZANE";"4.0";"666.70";"3";"-3.90";"CXA-101, FR-264205";"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1";"IC50";"'>'";"2.0";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1658204";"Inhibition of Pseudomonas aeruginosa PAO1 PBP5/6 by SDS-PAGE";"B";"BAO_0000019";"assay format";"Pseudomonas aeruginosa PAO1";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1649308";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"None";"";"";"";"2.0"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"17.5";"nM";"7.76";"";"335039";"UO_0000065";"22.99";"0.46";"6.31";"8.53";"0";"CHEMBL3887373";"Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2971";"Tyrosine-protein kinase JAK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886293";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"17.5"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"75.1";"nM";"7.12";"";"335043";"UO_0000065";"21.11";"0.42";"5.67";"7.83";"0";"CHEMBL3887375";"Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886293";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"75.1"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5353930";"Inhibition of IGF1R (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1957";"Insulin-like growth factor I receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5353927";"Inhibition of PTK2B (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5469";"Protein tyrosine kinase 2 beta";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909179";"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)";"B";"BAO_0000357";"single protein format";"Escherichia coli";"None";"None";"None";"None";"";"";"";"CHEMBL3464";"Nitric oxide synthase, inducible";"Mus musculus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909182";"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL233";"Mu opioid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909190";"DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL240";"HERG";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909192";"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)";"B";"BAO_0000221";"tissue-based format";"Oryctolagus cuniculus";"CHEMBL3638235";"Lung";"None";"None";"";"";"";"CHEMBL4074";"Angiotensin-converting enzyme";"Oryctolagus cuniculus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL3877186";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875233";"1";"Scientific Literature";"Nat Rev Drug Discov";"2017";"None";"";"";"";"4.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL3877184";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875233";"1";"Scientific Literature";"Nat Rev Drug Discov";"2017";"None";"";"";"";"1.0"
"CHEMBL3348963";"TELOTRISTAT ETIPRATE";"4.0";"754.17";"1";"4.99";"33";"CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1.O=C(O)CNC(=O)c1ccccc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"10.70";"0.21";"1.16";"4.69";"0";"CHEMBL5331999";"Inhibition of human TPH1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5689";"Tryptophan 5-hydroxylase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331057";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.7"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"15";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"7.943";"nM";"8.10";"";"";"UO_0000065";"20.38";"0.38";"5.68";"7.79";"0";"CHEMBL4386405";"Inhibition of dye-labeled tracer binding to HDAC10 (unknown origin) transfected in human HeLa cells measured after 2 hrs by nano-luciferase reporter gene-based BRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL5103";"Histone deacetylase 10";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385610";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308376";"";"";"";"8.1"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"Tafamidis";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"17.07";"0.36";"0.76";"8.31";"0";"CHEMBL5327386";"Inhibition of acid mediated TTR V30M mutant aggregation (unknown origin) expressed in Escherichia coli preincubated for 30 mins followed by acetic buffer addition at pH 4.7 and measured after 7 days by thioflavin T based fluorescence analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"P02766";"V50M";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325452";"1";"Scientific Literature";"Bioorg Med Chem";"2023";"None";"TIME = 168.0 hr";"INHIBITOR";"";"5.5"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909159";"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909164";"DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL1798";"Cysteinyl leukotriene receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"19.93";"0.37";"5.50";"7.61";"0";"CHEMBL4771398";"Inhibition of human HDAC6 expressed in baculovirus infected sf9 cells using p53 residues 379-382 (RHKKAc) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1865";"Histone deacetylase 6";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"12.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"17.18";"0.32";"4.41";"6.56";"0";"CHEMBL4771392";"Inhibition of human HDAC3/NcoR2 expressed in sf9 cells using p53 residues 379-382 (RHKKAc) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2111363";"Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"148.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909096";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4607";"Angiotensin II type 2 (AT-2) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909166";"DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL4644";"Melanocortin receptor 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909186";"DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP)";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"Platelet";"None";"";"";"";"CHEMBL1827";"Phosphodiesterase 5A";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833781";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909197";"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL321";"Matrix metalloproteinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909098";"DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat))";"B";"BAO_0000249";"cell membrane format";"Cavia porcellus";"CHEMBL3638251";"Adrenal gland";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909112";"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3638188";"Brain";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909120";"DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL1889";"Vasopressin V1a receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909091";"DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL213";"Beta-1 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103803";"DAROTROPIUM BROMIDE";"None";"425.41";"0";"4.90";"4a";"C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2.[Br-]";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1061576";"Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL245";"Muscarinic acetylcholine receptor M3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153488";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";"";"10.0"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"3";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"11.65";"nM";"7.93";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614284";"Antiproliferative activity against human HeLa cells by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL399";"HeLa";"Homo sapiens";"CELL-LINE";"CHEMBL4613233";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3308376";"";"";"";"11.65"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"17.5";"nM";"7.76";"";"370424";"UO_0000065";"22.99";"0.46";"6.31";"8.53";"1";"CHEMBL3888064";"JAK Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3 and 60 minutes for Tyk-2.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2971";"Tyrosine-protein kinase JAK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886558";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"17.5"
"CHEMBL2105685";"AMUVATINIB HYDROCHLORIDE";"-1.0";"483.98";"0";"3.30";"MP470 HCl";"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3992022";"Potentiation of etoposide induced DNA damage in human DMS153 cells expressing Rad51 assessed as etoposide IC50 at 0.62 uM (Rvb IC50 = 0.29 uM)";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DMS-153";"None";"";"";"";"CHEMBL2366167";"DMS-153";"Homo sapiens";"CELL-LINE";"CHEMBL3991943";"38";"SureChEMBL Patent Bioactivity Data";"";"2013";"CHEMBL3308260";"";"";"";"0.026"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909126";"DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL274";"C-C chemokine receptor type 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909132";"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BTI-TN-5B1-4";"None";"";"";"";"CHEMBL3356";"Cytochrome P450 1A2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833782";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"21.61";"0.40";"6.29";"9.25";"0";"CHEMBL4830394";"Inhibition of human CDK9/cyclin-T1 using KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as substrate incubated for 2 hrs by [gamma-33P]-ATP assay";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2111389";"CDK9/cyclin T1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4828743";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR";"";"2.7"
"CHEMBL2103855";"TELOTRISTAT";"4.0";"546.94";"1";"4.51";"1-2";"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"11.24";"0.22";"1.64";"4.32";"1";"CHEMBL5374997";"Inhibition of recombinant MBP-tagged full length human THP2 using L-Trp as substrate assessed as formation of 5-HTP by measuring fluorescent property";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5433";"Tryptophan 5-hydroxylase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370659";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.71"
"CHEMBL2103872";"CEFTOLOZANE";"4.0";"666.70";"3";"-3.90";"CXA-101, FR-264205";"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1";"IC50";"'='";"0.29";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1658203";"Inhibition of Pseudomonas aeruginosa PAO1 PBP4 by SDS-PAGE";"B";"BAO_0000019";"assay format";"Pseudomonas aeruginosa PAO1";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1649308";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"None";"";"";"";"0.29"
"CHEMBL2103772";"RACECADOTRIL";"4.0";"385.49";"0";"2.98";"racecadotril";"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1";"IC50";"'='";"2930000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162022";"Cytotoxicity against human KB-3-1 cells incubated for 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KB 3-1";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL2157950";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307659";"";"";"";"2.93"
"CHEMBL4103870";"";"None";"363.44";"1";"5.43";"12f";"O=C(c1ccc([N+](=O)[O-])cc1)c1c(-c2ccccc2)sc2c1CCCC2";"IC50";"'='";"20470.0";"nM";"4.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3994723";"Antiproliferative activity against human A375 cells after 48 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A-375";"None";"";"";"";"CHEMBL613859";"A-375";"Homo sapiens";"CELL-LINE";"CHEMBL3994563";"1";"Scientific Literature";"Medchemcomm";"2016";"CHEMBL3308077";"";"";"";"20.47"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"1";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4686978";"Antiproliferative activity against human A375 cells harboring BRAF V600E mutant assessed as inhibition of cell viability after 96 hrs by Celltiter-Glo assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A375/R";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4680253";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 96.0 hr";"";"";"0.0024"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"31; ARRY-334543, ASLAN001";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"17.46";"0.35";"2.90";"8.72";"1";"CHEMBL4342876";"Inhibition of human recombinant full length EGFR using polyglutamic acid/tyrosine as substrate by spectrophotometry";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL203";"Epidermal growth factor receptor erbB1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342409";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"7.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909161";"DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"NIH3T3";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307716";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'<'";"5.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380102";"Cytotoxicity against human NCI-H929 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL4295412";"";"";"";"0.005"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909154";"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909170";"DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL216";"Muscarinic acetylcholine receptor M1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103873";"MACITENTAN";"4.0";"588.28";"1";"3.57";"COVC-2833803927";"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909215";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL256";"Adenosine A3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5353926";"Inhibition of AXL (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4895";"Tyrosine-protein kinase receptor UFO";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5353929";"Inhibition of JAK1 (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2835";"Tyrosine-protein kinase JAK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"";"";""
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"19.32";"0.36";"5.26";"7.38";"0";"CHEMBL4771390";"Inhibition of human HDAC1 expressed in baculovirus infected sf9 cells using p53 residues 379-382 (RHKKAc) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL325";"Histone deacetylase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"21.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"11; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"0";"CHEMBL3856517";"Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated Histone H1 as substrate after 1 hr in presence of 33P-ATP by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856187";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308860";"";"";"";"1.0"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"7.18";"nM";"8.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5109757";"Cytotoxicity against KK-LC-1-negative human HGC-27 cells incubated for 72 hrs by CCK-8 assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HGC-27";"None";"";"";"";"CHEMBL1075463";"HGC-27";"Homo sapiens";"CELL-LINE";"CHEMBL5108004";"1";"Scientific Literature";"Eur J Med Chem";"2022";"CHEMBL3308741";"TIME = 72.0 hr";"";"";"7.18"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5224413";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223102";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909139";"DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL2056";"Dopamine D1 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";"";"";"";""
"CHEMBL2103855";"TELOTRISTAT";"4.0";"546.94";"1";"4.51";"COVC-1746063739";"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909172";"DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL245";"Muscarinic acetylcholine receptor M3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909198";"DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL299";"Protein kinase C alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308860";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909125";"DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"Chem-1";"Membrane";"";"";"";"CHEMBL2414";"C-C chemokine receptor type 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909141";"DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL234";"Dopamine D3 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909169";"DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BTI-TN-5B1-4";"None";"";"";"";"CHEMBL1951";"Monoamine oxidase A";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833782";"";"";"";""
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"1";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731101";"Inhibition of gamma secretase in mouse N2a695 cells using Sb4 substrate incubated for 3 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"N2a695";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4725444";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"";"";"30.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5230717";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230096";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"19.76";"0.37";"5.43";"7.55";"0";"CHEMBL4771400";"Inhibition of human HDAC11 expressed in baculovirus infected sf9 cells using (Boc-Lys(trifluoroacetyl)-AMC) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3310";"Histone deacetylase 11";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"14.0"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"31; ARRY-334543, ASLAN001";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.63";"0.37";"3.45";"9.30";"1";"CHEMBL4342877";"Inhibition of human recombinant His-tagged HER2 (catalytic domain 691 to 1255 residues) using polyglutamic acid/tyrosine as substrate by spectrophotometry";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1824";"Receptor protein-tyrosine kinase erbB-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342409";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"2.0"
"CHEMBL3348963";"TELOTRISTAT ETIPRATE";"4.0";"754.17";"1";"4.99";"33";"CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1.O=C(O)CNC(=O)c1ccccc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5332001";"Antiproliferative activity against rat RBL-2H3 cells assessed as inhibition of growth inhibition";"F";"BAO_0000219";"cell-based format";"Rattus norvegicus";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL614632";"RBL-2H3";"Rattus norvegicus";"CELL-LINE";"CHEMBL5331057";"1";"Scientific Literature";"Eur J Med Chem";"2022";"CHEMBL3307666";"";"";"";"0.4"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421237";"Antiproliferative activity against human MDA-MB-231 cells after 4 days by XTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL400";"MDA-MB-231";"Homo sapiens";"CELL-LINE";"CHEMBL2417433";"1";"Scientific Literature";"Eur J Med Chem";"2013";"CHEMBL3307960";"";"";"";"0.25"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5152799";"Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter-96 assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL399";"HeLa";"Homo sapiens";"CELL-LINE";"CHEMBL5150030";"1";"Scientific Literature";"J Med Chem";"2022";"CHEMBL3308376";"TIME = 72.0 hr";"";"";"1.1"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"75.1";"nM";"7.12";"";"370428";"UO_0000065";"21.11";"0.42";"5.67";"7.83";"1";"CHEMBL3888066";"JAK Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3 and 60 minutes for Tyk-2.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886558";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"75.1"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"95.1";"nM";"7.02";"";"335041";"UO_0000065";"20.81";"0.42";"5.57";"7.72";"0";"CHEMBL3887374";"Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2148";"Tyrosine-protein kinase JAK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886293";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"95.1"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445900";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line COLO205, B-Raf mutation)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"COLO 205";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3308348";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"0.52"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"174.0";"nM";"6.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445902";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line HCT-15, K-Ras mutation)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-15";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307945";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"174.0"
"CHEMBL2030870";"";"None";"299.30";"0";"0.28";"16";"O=C(O)C(=O)N[C@@H](CSCc1ccccc1O)C(=O)O";"IC50";"'='";"50400.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034755";"Inhibition of Escherichia coli AlkB deltaN11 mutant using 5'-TTCmTTTTTTTTTTTT-3'-fluorescein as substrate after 4.5 mins by capillary electrophoresis-based laser-induced fluorescence assay";"B";"BAO_0000019";"assay format";"Escherichia coli";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL2029258";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"50.4"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909214";"DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL251";"Adenosine A2a receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880540";"Growth inhibition of human MV522 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MV522";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"None";"";"";"";"0.001"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4830412";"Inhibition of human TRKC using poly[Glu:Tyr] (4:1) as substrate incubated for 2 hrs by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5608";"NT-3 growth factor receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4828743";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL5224411";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223102";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";"";"4.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"20.94";"0.39";"6.02";"8.96";"0";"CHEMBL5224415";"Inhibition of CDK5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223102";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";"";"5.0"
"CHEMBL2103855";"TELOTRISTAT";"4.0";"546.94";"1";"4.51";"1-2";"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1";"IC50";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5374996";"Inhibition of recombinant MBP-tagged full length human THP1 using L-Trp as substrate assessed as formation of 5-HTP by measuring fluorescent property";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL5689";"Tryptophan 5-hydroxylase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370659";"1";"Scientific Literature";"J Med Chem";"2023";"CHEMBL3307574";"";"INHIBITOR";"";"0.77"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"Tibolone";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909203";"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Insect cells";"None";"";"";"";"CHEMBL203";"Epidermal growth factor receptor erbB1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5352097";"Inhibition of HDAC8 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3192";"Histone deacetylase 8";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"1000.0"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4481444";"Cytotoxicity in human NCI-H524 cells pre-incubated for 2 hrs followed by compound wash out and subsequently incubated for 70 hrs by Cell Titer Glo assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H524";"None";"";"";"";"CHEMBL2366342";"NCI-H524";"Homo sapiens";"CELL-LINE";"CHEMBL4480406";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308296";"";"";"";"3.7"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445913";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line LS-174T, K-Ras mutation)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LS174T";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307536";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"4.1"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL4346792";"Inhibition of recombinant CDK9 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of cyclin by [33P]-ATP-based liquid scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346652";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"4.0"
"CHEMBL2103803";"DAROTROPIUM BROMIDE";"None";"425.41";"0";"4.90";"34";"C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2.[Br-]";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1786272";"Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL245";"Muscarinic acetylcholine receptor M3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1781884";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308072";"";"";"";"10.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"38; GSK1120212";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"14.68";"0.33";"5.10";"8.43";"0";"CHEMBL5131722";"Inhibition of MEK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.92"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"38; GSK1120212";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"14.21";"0.32";"4.80";"8.16";"0";"CHEMBL5131723";"Inhibition of MEK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.8"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"38; GSK1120212";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"14.68";"0.33";"5.10";"8.43";"0";"CHEMBL5131619";"Non competitive inhibition of MEK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.92"
"CHEMBL1200870";"TIMOLOL MALEATE";"4.0";"432.50";"0";"0.50";"NCGC00094442-01";"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\C(=O)O";"IC50";"'='";"12589.25";"nM";"4.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1267251";"Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay";"F";"BAO_0000218";"organism-based format";"Plasmodium falciparum";"None";"None";"None";"None";"";"";"";"CHEMBL364";"Plasmodium falciparum";"Plasmodium falciparum";"ORGANISM";"CHEMBL1255382";"1";"Scientific Literature";"Nat Chem Biol";"2009";"None";"";"";"";"-4.9"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"15";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4701898";"Inhibition of MEK in human KYSE-520 cells assessed as reduction in p-ERK levels";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KYSE-520 cell line";"None";"";"";"";"CHEMBL2111289";"Dual specificity mitogen-activated protein kinase kinase; MEK1/2";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL4699491";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.001"
"CHEMBL2103773";"OTILONIUM BROMIDE";"3.0";"563.58";"1";"6.32";"SID170466098";"CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1.[Br-]";"IC50";"";"10000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3562043";"PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) ";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"10.0"
"CHEMBL2104850";"RILAPINE";"2.0";"361.88";"0";"4.35";"COVC-2286540340";"CN1CCN(C2=Cc3cc(Cl)ccc3/C(=C/C#N)c3ccccc32)CC1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"9.53";"nM";"8.02";"";"335037";"UO_0000065";"23.77";"0.48";"6.57";"8.82";"0";"CHEMBL3887372";"Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2835";"Tyrosine-protein kinase JAK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886293";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"9.53"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"414.0";"nM";"6.38";"";"";"UO_0000065";"16.10";"0.30";"4.10";"6.89";"0";"CHEMBL4830409";"Inhibition of human GSK3A using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate incubated for 2 hrs by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2850";"Glycogen synthase kinase-3 alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4828743";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR";"";"414.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"324.0";"nM";"6.49";"";"";"UO_0000065";"16.37";"0.31";"4.21";"7.01";"0";"CHEMBL4830410";"Inhibition of human GSK3B using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate incubated for 2 hrs by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL262";"Glycogen synthase kinase-3 beta";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4828743";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR";"";"324.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"19.1";"nM";"7.72";"";"";"UO_0000065";"19.42";"0.36";"5.30";"7.42";"0";"CHEMBL5352099";"Inhibition of HDAC6 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1865";"Histone deacetylase 6";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"19.1"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"COVC-3357334973";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"19.66";"0.37";"5.52";"8.42";"0";"CHEMBL5048671";"Inhibition of Nano-Luc fused human full length CDK5/P35 transfected in HEK293 cells incubated for 1 hr by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL1907600";"Cyclin-dependent kinase 5/CDK5 activator 1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5046275";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"16.0"
"CHEMBL2103828";"ELINOGREL";"2.0";"523.96";"1";"3.09";"Elinogrel";"CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3802953";"Displacement of [3H]-2-Mes-ADP from human P2Y12 receptor in platelets by scintillation counter";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2001";"Purinergic receptor P2Y12";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"0.01"
"CHEMBL2103851";"AMUVATINIB";"2.0";"447.52";"0";"3.30";"HPK56; III-1-3";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"12.95";"0.25";"2.50";"7.64";"0";"CHEMBL3882683";"Inhibition of c-kit gain of function mutant in human GIST882 cells measured after 4 days by sulforhodamine B assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"UNDEFINED MUTATION";"CHEMBL1936";"Stem cell growth factor receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882391";"38";"SureChEMBL Patent Bioactivity Data";"";"2008";"None";"";"";"";"1.6"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"11; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"0";"CHEMBL3856515";"Inhibition of recombinant CDK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated Histone H1 as substrate after 1 hr in presence of 33P-ATP by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856187";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308860";"";"";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"17.39";"0.32";"4.62";"7.44";"0";"CHEMBL3767307";"Inhibition of CDK4/Cyclin D1 (unknown origin) using RPPTLSPIPHIPR peptide as substrate in presence of [gamma-33P]ATP";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907601";"Cyclin-dependent kinase 4/cyclin D1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3763042";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"0.127"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"178.0";"nM";"6.75";"";"";"UO_0000065";"17.02";"0.32";"4.47";"7.29";"0";"CHEMBL3767463";"Inhibition of CDK9/Cyclin T1 (unknown origin) using (YSPTSPS)2KK peptide as substrate in presence of [gamma-33P]ATP";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2111389";"CDK9/cyclin T1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3763042";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"0.178"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4836767";"Antiproliferative activity against human K562 cells assessed as cell death measured after 72 hrs by resazurin dye based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"K562";"None";"";"";"";"CHEMBL385";"K562";"Homo sapiens";"CELL-LINE";"CHEMBL4834472";"1";"Scientific Literature";"J Med Chem";"2021";"CHEMBL3308378";"TIME = 72.0 hr";"";"";"0.013000000000000001"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"Tafamidis";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"17.12";"0.36";"0.78";"8.33";"0";"CHEMBL4813813";"Inhibition of acid-mediated aggregation of TTR V30M mutant (unknown origin) expressed in Escherichia coli pretreated for 30 mins at pH 7 followed by protein dilution in acetate buffer and further incubated for 96 hrs at pH 4.6 by thioflavin-T fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811317";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 96.5 hr";"INHIBITOR";"";"5.3"
"CHEMBL1203370";"";"None";"527.10";"1";"6.24";"33";"Cl.Fc1ccc(C(OCCN2CCC3CCC(C2)N3CCCc2ccccc2)c2ccc(F)cc2)cc1";"IC50";"'='";"2080.0";"nM";"5.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL619191";"Inhibition of [3H]5-HT reuptake in whole rat brain (minus cerebellum) homogenate.";"F";"BAO_0000221";"tissue-based format";"Rattus norvegicus";"CHEMBL3638233";"Cerebellum";"None";"None";"";"";"";"CHEMBL313";"Serotonin transporter";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1133553";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";"";"2080.0"
"CHEMBL2103877";"EFINACONAZOLE";"4.0";"348.40";"0";"2.48";"ECZ";"C=C1CCN([C@H](C)[C@](O)(Cn2cncn2)c2ccc(F)cc2F)CC1";"IC50";"'='";"1.0";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5032226";"Induction of drug resistance in Candida glabrata BG2 assessed as increase in ECZ IC50 at 8 times IC50 after 4 days";"F";"BAO_0000218";"organism-based format";"Nakaseomyces glabratus";"None";"None";"None";"None";"";"";"";"CHEMBL612647";"Nakaseomyces glabratus";"Nakaseomyces glabratus";"ORGANISM";"CHEMBL5030558";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 96.0 hr";"";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"11; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"0";"CHEMBL3856518";"Inhibition of recombinant CDK9 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated Histone H1 as substrate after 1 hr in presence of 33P-ATP by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856187";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308860";"";"";"";"4.0"
"CHEMBL2103852";"CROLIBULIN";"2.0";"417.26";"0";"2.85";"Crolibulin";"COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147469";"Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HT-29";"None";"";"";"";"CHEMBL384";"HT-29";"Homo sapiens";"CELL-LINE";"CHEMBL4145506";"1";"Scientific Literature";"Eur J Med Chem";"2018";"CHEMBL3307768";"";"";"";"0.55"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"4";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"981.0";"nM";"6.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033187";"Disruption of retional-induced bacterially expressed MBP-tagged RBP4-TTR (unknown origin) protein-protein interaction measured by d2 dye based HTFR assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5032506";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.981"
"CHEMBL2103824";"ARHALOFENATE";"2.0";"415.80";"0";"4.16";"COVC-3894562307";"CC(=O)NCCOC(=O)[C@H](Oc1cccc(C(F)(F)F)c1)c1ccc(Cl)cc1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"3";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"22.95";"0.46";"6.29";"8.51";"1";"CHEMBL4481925";"Inhibition of human recombinant JAK2 (808 to 1132 residues) by Z-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2971";"Tyrosine-protein kinase JAK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480435";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"18.0"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"9.53";"nM";"8.02";"";"370422";"UO_0000065";"23.77";"0.48";"6.57";"8.82";"1";"CHEMBL3888063";"JAK Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3 and 60 minutes for Tyk-2.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2835";"Tyrosine-protein kinase JAK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886558";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"9.53"
"CHEMBL2011870";"";"None";"302.40";"0";"3.72";"5";"COc1ccc(-c2nsc(NC(=O)[C@@H]3C[C@H]3C)c2C)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2344545";"Negative allosteric modulation of human recombinant mGlu1 receptor expressed in Syrian hamster AV12 cells assessed as receptor-mediated changes in intracellular calcium concentration by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"AV12";"None";"";"";"";"CHEMBL3772";"Metabotropic glutamate receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2331451";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"9.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4812200";"Inhibition of human CDK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811242";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909189";"DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HIT-T15";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909095";"DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde)";"B";"BAO_0000221";"tissue-based format";"Rattus norvegicus";"CHEMBL3638191";"Lens of camera-type eye";"None";"None";"";"";"";"CHEMBL2622";"Aldose reductase";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909121";"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3638188";"Brain";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909124";"DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL4015";"C-C chemokine receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909163";"DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)";"B";"BAO_0000221";"tissue-based format";"Cavia porcellus";"CHEMBL3638235";"Lung";"None";"None";"";"";"";"CHEMBL1909043";"Leukotriene C4 synthase";"Cavia porcellus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"11";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"23.71";"0.48";"6.55";"8.79";"1";"CHEMBL5245505";"Inhibition of recombinant human JAK1 (852 to 1142 residues)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2835";"Tyrosine-protein kinase JAK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"1";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"8.48";"0.17";"1.83";"2.64";"0";"CHEMBL2350850";"Inhibition of SYK in human whole blood";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL2599";"Tyrosine-protein kinase SYK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346624";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"12.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5353920";"Antiproliferative activity against human PL45 cells assessed as growth inhibition incubated for 24 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PL45";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 24.0 hr";"";"";"0.015"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"11; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"0";"CHEMBL3856487";"Inhibition of recombinant CDK2/cyclin A (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated histone H1 as substrate after 1 hr by gamma32P-ATP based liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3038469";"CDK2/Cyclin A2";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3856187";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308860";"";"";"";"1.0"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"11";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"22.95";"0.46";"6.29";"8.51";"1";"CHEMBL5245506";"Inhibition of recombinant human JAK2 (808 to 1132 residues)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2971";"Tyrosine-protein kinase JAK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"18.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4830408";"Inhibition of human FLT3 using EAIYAAPFAKKK as substrate incubated for 2 hrs by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1974";"Tyrosine-protein kinase receptor FLT3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4828743";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"";"";""
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"44";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"12.73";"0.25";"4.30";"3.96";"0";"CHEMBL5332009";"Inhibition of SYK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2599";"Tyrosine-protein kinase SYK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331057";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"41.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445908";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line LoVo, K-Ras mutation)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LoVo";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307691";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"2.2"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"10; SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL5253662";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252533";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"INHIBITOR";"";"4.0"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"30";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.38";"0.27";"4.68";"4.16";"1";"CHEMBL5253668";"Inhibition of SYK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2599";"Tyrosine-protein kinase SYK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252533";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"INHIBITOR";"";"17.0"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"8, STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"22.78";"0.42";"5.05";"8.64";"0";"CHEMBL2424067";"Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from recombinant HSP90beta (unknown origin) after 24 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4303";"Heat shock protein HSP 90-beta";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417440";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"5.0"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"4";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"20.73";"0.44";"1.89";"10.09";"0";"CHEMBL5033188";"Binding affinity to human plasma TTR tetramer assessed as displacement of diclofenac-coupled FITC by fluorescence polarization assay";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"None";"Plasma";"None";"None";"";"";"";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032506";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"STABILISER";"";"0.41"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"10; SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"18700.0";"nM";"4.73";"";"";"UO_0000065";"11.92";"0.22";"2.45";"5.10";"0";"CHEMBL5253659";"Inhibition of human N-terminal His6-tagged BRDT (21 to 137 residues) expressed in Escherichia coli BL21 (DE3) cells incubated for 1 hr";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1795185";"Bromodomain testis-specific protein";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252533";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 1.0 hr";"INHIBITOR";"";"18.7"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"22.56";"0.42";"4.97";"8.56";"0";"CHEMBL5371246";"Inhibition of human recombinant HSP90alpha preincubated for 30 mins followed by FITC-GM addition and mesured after 3 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3880";"Heat shock protein HSP 90-alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370536";"1";"Scientific Literature";"Eur J Med Chem";"2023";"None";"TIME = 3.5 hr";"INHIBITOR";"";"0.006"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"6840.0";"nM";"5.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5371248";"Antiproliferative activity against human Temozolomide-sensitive U-251 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-251";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL5370536";"1";"Scientific Literature";"Eur J Med Chem";"2023";"CHEMBL3307756";"TIME = 48.0 hr";"";"";"6.84"
"CHEMBL2103856";"ATOPAXAR";"2.0";"527.64";"1";"4.79";"COVC-2820811880";"CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"Varlitinib";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5227183";"Anticancer activity against human Hs-578T cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Hs-578T";"None";"";"";"";"CHEMBL614645";"Hs-578T";"Homo sapiens";"CELL-LINE";"CHEMBL5226297";"1";"Scientific Literature";"J Med Chem";"2021";"CHEMBL3307672";"TIME = 72.0 hr";"";"";"10.0"
"CHEMBL1203370";"";"None";"527.10";"1";"6.24";"33";"Cl.Fc1ccc(C(OCCN2CCC3CCC(C2)N3CCCc2ccccc2)c2ccc(F)cc2)cc1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"14.03";"0.26";"0.65";"43.83";"0";"CHEMBL673210";"Binding affinity for rat Dopamine transporter.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL338";"Dopamine transporter";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1133553";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";"";"130.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"8";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5123395";"Inhibition of CDK5/p35 (unknown origin)";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907600";"Cyclin-dependent kinase 5/CDK5 activator 1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5120846";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103851";"AMUVATINIB";"2.0";"447.52";"0";"3.30";"13; MP470";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3811330";"Inhibition of AXL in human GIST cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"GIST";"None";"";"";"";"CHEMBL4895";"Tyrosine-protein kinase receptor UFO";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808287";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"1.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5352100";"Inhibition of HDAC11 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3310";"Histone deacetylase 11";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"1000.0"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5371245";"Inhibition of MAO A in mouse GL26 cells preincubated for 20 mins followed by 14C-labeled 5-hydroxytryptamine addition and measured after 20 mins by scintillation counter analysis";"B";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"GL26";"None";"";"";"";"CHEMBL3681";"Monoamine oxidase A";"Mus musculus";"SINGLE PROTEIN";"CHEMBL5370536";"1";"Scientific Literature";"Eur J Med Chem";"2023";"None";"TIME = 0.6667 hr";"";"";"10.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5230721";"Inhibition of CDK5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230096";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103872";"CEFTOLOZANE";"4.0";"666.70";"3";"-3.90";"CXA-101, FR-264205";"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1";"IC50";"'='";"0.07";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1658199";"Inhibition of Pseudomonas aeruginosa PAO1 PBP1b by SDS-PAGE";"B";"BAO_0000019";"assay format";"Pseudomonas aeruginosa PAO1";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1649308";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"None";"";"";"";"0.07"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"1";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4686982";"Antiproliferative activity against human HL60 cells harboring NRAS K61L mutant assessed as inhibition of cell viability after 96 hrs by Celltiter-Glo assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HL-60";"None";"";"";"";"CHEMBL383";"HL-60";"Homo sapiens";"CELL-LINE";"CHEMBL4680253";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3307654";"TIME = 96.0 hr";"";"";"0.003"
"CHEMBL2103772";"RACECADOTRIL";"4.0";"385.49";"0";"2.98";"Racecadotril";"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1";"IC50";"'='";"99000.0";"nM";"4.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4028923";"Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5918";"Canalicular multispecific organic anion transporter 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028801";"1";"Scientific Literature";"Toxicol Sci";"2013";"None";"";"";"";"99.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4429336";"Antiparasitic activity against bloodstream form of Trypanosoma brucei 221 infected in mouse VSMC assessed as reduction in parasitic proliferation after 48 hrs by cell titer-glo based assay";"F";"BAO_0000218";"organism-based format";"Trypanosoma brucei";"None";"None";"None";"None";"";"";"";"CHEMBL612849";"Trypanosoma brucei";"Trypanosoma brucei";"ORGANISM";"CHEMBL4428064";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";"";"80.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"22.18";"0.41";"6.52";"9.50";"0";"CHEMBL5048662";"Inhibition of full length N-terminal GST fused human CDK5(1 to 292 residues)/ p25 (99 to 307 residues) expressed in baculovirus expression system using FL peptide as substrate preincubated for 30 mins followed by substrate addition further incubated for 60 mins by EZ reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907600";"Cyclin-dependent kinase 5/CDK5 activator 1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5046275";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";"";"1.6"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"0";"CHEMBL4841250";"Inhibition of CDK4 (unknown origin) expressed in Sf9 insect cells incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL331";"Cyclin-dependent kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840335";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909088";"DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"Sf9";"Membrane";"";"";"";"CHEMBL1867";"Alpha-2a adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308860";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909087";"DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL223";"Alpha-1d adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5352091";"Cytotoxicity against human Bel-7402 cells incubated for 72 hrs measured by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Bel-7402";"None";"";"";"";"CHEMBL614279";"Bel-7402";"Homo sapiens";"CELL-LINE";"CHEMBL5346979";"1";"Scientific Literature";"J Med Chem";"2023";"CHEMBL3307770";"TIME = 72.0 hr";"";"";"0.37"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445917";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line LoVo, K-Ras mutation)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LoVo";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307691";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"2.2"
"CHEMBL1203890";"";"None";"445.38";"0";"3.54";"72";"CC(O)CN1CCN(C2CC(c3ccc(F)cc3)c3ccc(F)cc32)CC1.Cl.Cl";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL816027";"Ability to displace [3H]haloperidol from rat striatal membranes, in order to measure its intrinsic affinity for the dopamine (DA) receptor;NT=Not Tested";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2093868";"Dopamine receptor";"Rattus norvegicus";"PROTEIN FAMILY";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL5353305";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352406";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5353307";"Inhibition of CDK5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352406";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL5230716";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230096";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"3.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445912";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line HCT-116, K-Ras mutation)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3308372";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"5.7"
"CHEMBL2103851";"AMUVATINIB";"2.0";"447.52";"0";"3.30";"COVC-3894205475";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103851";"AMUVATINIB";"2.0";"447.52";"0";"3.30";"COVC-3894205475";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909103";"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909158";"DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA)";"B";"BAO_0000357";"single protein format";"Escherichia coli";"None";"None";"None";"None";"";"";"";"CHEMBL402";"HMG-CoA reductase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909165";"DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)";"B";"BAO_0000221";"tissue-based format";"Oryctolagus cuniculus";"None";"None";"Reticulocytes";"None";"";"";"";"CHEMBL4358";"Arachidonate 15-lipoxygenase";"Oryctolagus cuniculus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"8.5";"nM";"8.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445914";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line SW480, K-Ras mutation)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW480";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307758";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"8.5"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2379851";"Cytotoxicity against human BT549 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BT-549";"None";"";"";"";"CHEMBL614072";"BT-549";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308490";"";"";"";"10.0"
"CHEMBL2105699";"ATOPAXAR HYDROBROMIDE";"2.0";"608.55";"1";"4.79";"Example 1";"Br.CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"14.00";"0.27";"2.60";"8.76";"0";"CHEMBL3880486";"Antagonist activity at thrombin receptor in human platelet rich plasma assessed as inhibition of thrombin-induced platelet aggregation preincubated for 3 mins followed by thrombin addition measured after 6 mins by aggregometer";"B";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL3974";"Proteinase-activated receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3880385";"38";"SureChEMBL Patent Bioactivity Data";"";"2011";"None";"";"";"";"0.041"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"18.17";"0.34";"4.80";"6.94";"0";"CHEMBL4771394";"Inhibition of human HDAC4 expressed in baculovirus infected sf9 cells using (Boc-Lys(trifluoroacetyl)-AMC) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3524";"Histone deacetylase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"60.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880492";"Growth inhibition of human HCT8 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-8";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308035";"";"";"";"0.055"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880505";"Growth inhibition of human A549 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307651";"";"";"";"0.034"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"11; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL3856489";"Inhibition of recombinant CDK9/cyclin T (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated histone H1 as substrate after 1 hr by gamma32P-ATP based liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2111389";"CDK9/cyclin T1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3856187";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308860";"";"";"";"4.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880536";"Growth inhibition of human NCI-H1355 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H1355";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308876";"";"";"";"0.027"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"2; MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4220924";"Cytotoxicity against human A549 cells after 2 days by cell titer 96 aqueous one solution based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL4219075";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"CHEMBL3307651";"";"";"";"1.3"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880547";"Growth inhibition of human Calu3 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Calu-3";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307390";"";"";"";"0.039"
"CHEMBL2103772";"RACECADOTRIL";"4.0";"385.49";"0";"2.98";"Racecadotril";"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1";"IC50";"'>'";"133000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4028922";"Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5748";"Canalicular multispecific organic anion transporter 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028801";"1";"Scientific Literature";"Toxicol Sci";"2013";"None";"";"";"";"133.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"18.01";"0.34";"4.86";"7.71";"0";"CHEMBL3777410";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774312";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"0.072"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909150";"DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HeLa S3";"None";"";"";"";"CHEMBL2034";"Glucocorticoid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3886002";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909094";"DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"MDCK";"Membrane";"";"";"";"CHEMBL222";"Norepinephrine transporter";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308370";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909133";"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BTI-TN-5B1-4";"None";"";"";"";"CHEMBL5282";"Cytochrome P450 2A6";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833782";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909135";"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BTI-TN-5B1-4";"None";"";"";"";"CHEMBL3397";"Cytochrome P450 2C9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833782";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909146";"DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL242";"Estrogen receptor beta";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308860";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909148";"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3638188";"Brain";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2018370";"";"None";"479.54";"0";"3.49";"7b";"CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.31";"0.33";"4.81";"9.18";"0";"CHEMBL2019386";"Displacement of [125-I]MCP1 from CCR2 on human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4015";"C-C chemokine receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016523";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"5.0"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.59";"nM";"9.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421239";"Antiproliferative activity against human A549 cells after 4 days by XTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL2417433";"1";"Scientific Literature";"Eur J Med Chem";"2013";"CHEMBL3307651";"";"";"";"0.59"
"CHEMBL2103775";"ALACEPRIL";"2.0";"406.50";"0";"1.71";"COVC-2835348541";"CC(=O)SC[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"0.48";"nM";"9.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445899";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in HT-29 cells, B-Raf mutation)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HT-29";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307768";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"0.48"
"CHEMBL2103855";"TELOTRISTAT";"4.0";"546.94";"1";"4.51";"COVC-1746063739";"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"27";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"20.57";"0.38";"5.87";"8.80";"0";"CHEMBL3862054";"Inhibition of 17AAG-induced HSF1-mediated HSP72 expression in human U2OS cells preincubated for 1 hr followed by 17AAG addition measured after 18 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL5869";"Heat shock factor protein 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3861941";"1";"Scientific Literature";"Medchemcomm";"2016";"CHEMBL3307757";"";"";"";"7.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"18.12";"0.34";"4.78";"6.92";"0";"CHEMBL4771391";"Inhibition of human HDAC2 expressed in baculovirus infected sf9 cells using p53 residues 379-382 (RHKKAc) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1937";"Histone deacetylase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"63.0"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"3";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"23.71";"0.48";"6.55";"8.79";"0";"CHEMBL4481924";"Inhibition of human recombinant JAK1 (852 to 1142 residues) by Z-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2835";"Tyrosine-protein kinase JAK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480435";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"10.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880545";"Growth inhibition of human A427 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A-427";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307775";"";"";"";"0.01"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"14.29";"0.32";"4.86";"8.21";"0";"CHEMBL3135550";"Inhibition of B-Raf activated MEK2 (unknown origin) assessed as ERK2-mediated MBP phosphorylation after 30 mins by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3132762";"1";"Scientific Literature";"Medchemcomm";"2014";"None";"";"";"";"1.6"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.19";"nM";"8.38";"";"";"UO_0000065";"21.13";"0.39";"6.10";"9.04";"0";"CHEMBL5353922";"Inhibition of CDK2 (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"4.19"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"3; SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL4348725";"Inhibition of recombinant CDK9 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated peptide as substrate after 1 hr in presence of [33P]ATP by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346699";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";"";"4.0"
"CHEMBL2103851";"AMUVATINIB";"2.0";"447.52";"0";"3.30";"HPK56; III-1-3";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"12.95";"0.25";"2.50";"7.64";"0";"CHEMBL3882690";"Inhibition of c-kit gain of function mutant in human GIST882 cells after 96 hrs by Cell-Titer Glo luciferase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"UNDEFINED MUTATION";"CHEMBL1936";"Stem cell growth factor receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882391";"38";"SureChEMBL Patent Bioactivity Data";"";"2008";"None";"";"";"";"1.6"
"CHEMBL2103851";"AMUVATINIB";"2.0";"447.52";"0";"3.30";"HPK56; III-1-3";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"12.69";"0.24";"2.38";"7.48";"0";"CHEMBL3882684";"Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MIA PaCa-2";"None";"";"";"";"CHEMBL2007";"Platelet-derived growth factor receptor alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3882391";"38";"SureChEMBL Patent Bioactivity Data";"";"2008";"CHEMBL3308500";"";"";"";"2.1"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"Ganetespib";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"5390.0";"nM";"5.27";"";"";"UO_0000065";"14.46";"0.27";"2.02";"5.48";"0";"CHEMBL5144552";"Inhibition of human HSP90";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2095165";"Heat shock protein HSP90";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL5143528";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"5.39"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"0";"CHEMBL4386147";"Inhibition of GST-tagged CDK2/Cyclin-A2 (unknown origin) expressed in Escherichia coli using histone H1 as substrate measured in presence of [gamma-33P]ATP";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3038469";"CDK2/Cyclin A2";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.003"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909157";"DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL1941";"Histamine H2 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380099";"Cytotoxicity against human MNNG-HOS cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HOS-TE85";"None";"";"";"";"CHEMBL614038";"HOS-TE85";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307282";"";"";"";"0.0055"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"329.0";"nM";"6.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880504";"Growth inhibition of human COR-L23 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"COR-L23";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308073";"";"";"";"0.329"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880509";"Growth inhibition of human Calu6 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Calu-6";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307639";"";"";"";"0.004"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"4";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL4403339";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402527";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"12";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL4701389";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699469";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"4.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445916";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line T84, K-Ras mutation)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T84";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307275";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"36.0"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"COVC-2283593047";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"13";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4009227";"Inhibition of recombinant human LTA4H Epoxide Hydrolase expressed in Escherichia coli BL21 (DE3) pLysS preincubated for 10 mins followed by addition of LTA4 as substrate measured after 15 mins by reverse-phase HPLC analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4618";"Leukotriene A4 hydrolase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007425";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880489";"Growth inhibition of human MDA-MB-175-VII cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-175-VII";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308404";"";"";"";"0.096"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"158.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880517";"Growth inhibition of human Calu3 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Calu-3";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307390";"";"";"";"0.158"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880530";"Growth inhibition of human SW1463 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW1463";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308788";"";"";"";"0.004"
"CHEMBL2103856";"ATOPAXAR";"2.0";"527.64";"1";"4.79";"COVC-2820811880";"CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880497";"Growth inhibition of human SW837 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW837";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308361";"";"";"";"0.074"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880528";"Growth inhibition of human LS1034 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LS-1034";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308846";"";"";"";"0.004"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880491";"Growth inhibition of human RKO cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RKO";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307731";"";"";"";"0.018"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4738663";"Inhibition of recombinant CDK2 (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated Histone H1 peptide as substrate incubated for 1 hr in presence of [33P]ATP by liquid scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732230";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.001"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4738664";"Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated Histone H1 peptide as substrate incubated for 1 hr in presence of [33P]ATP by liquid scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732230";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.001"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL4738665";"Inhibition of recombinant CDK9 (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated Histone H1 peptide as substrate incubated for 1 hr in presence of [33P]ATP by liquid scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732230";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.004"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5371249";"Antiproliferative activity against human Temozolomide-resistant U-251 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-251";"None";"";"";"";"CHEMBL615022";"U-251";"Homo sapiens";"CELL-LINE";"CHEMBL5370536";"1";"Scientific Literature";"Eur J Med Chem";"2023";"CHEMBL3307756";"TIME = 48.0 hr";"";"";"10.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880502";"Growth inhibition of human SW480 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW480";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307758";"";"";"";"0.037"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880522";"Growth inhibition of human HCT8 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-8";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308035";"";"";"";"0.014"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880519";"Growth inhibition of human MDA-MB-175-VII cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-175-VII";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308404";"";"";"";"0.016"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880534";"Growth inhibition of human COR-L23 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"COR-L23";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308073";"";"";"";"0.037"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880542";"Growth inhibition of human SW1573 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW1573";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307980";"";"";"";"0.038"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"11; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"0";"CHEMBL3856516";"Inhibition of recombinant CDK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated Histone H1 as substrate after 1 hr in presence of 33P-ATP by liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856187";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308860";"";"";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2379852";"Cytotoxicity against human RPMI18226 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RPMI18226";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"0.009"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2379853";"Cytotoxicity against human SW872 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW872";"None";"";"";"";"CHEMBL2366302";"SW872";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308837";"";"";"";"0.0095"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"Tafamidis";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"1550.0";"nM";"5.81";"";"";"UO_0000065";"18.86";"0.40";"1.31";"9.17";"0";"CHEMBL3871570";"Inhibition of wild type TTR (unknown origin) assessed as inhibition of acid-mediated amyloidogenesis by measuring fibril formation preincubated with enzyme followed by amyloidogenesis stimulation by adjusting pH to 4.4 measured after 72 hrs relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3871272";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"1.55"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445910";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line COLO320 DM, WT)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"COLO 320";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307577";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"10000.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"13.76";"0.31";"4.53";"7.90";"0";"CHEMBL5478718";"Selectivity interaction (ELISA (Raf-MEK-ERK cascade kinase assay, activated with B-Raf)) EUB0000124b MAP2K1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Remarks: In-vitro potency (using 10 uM ATP) | Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"3.4"
"CHEMBL2103772";"RACECADOTRIL";"4.0";"385.49";"0";"2.98";"Racecadotril";"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1";"IC50";"'>'";"133000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4028924";"Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1743128";"Multidrug resistance-associated protein 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028801";"1";"Scientific Literature";"Toxicol Sci";"2013";"None";"";"";"";"133.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"18.53";"0.35";"5.07";"7.93";"0";"CHEMBL3777412";"Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774312";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"0.045"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"49";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"18.66";"0.35";"5.12";"7.99";"0";"CHEMBL4775152";"Inhibition of human CDK12 (696 to 1082 residues)/human cyclinK (1 to 267 residues) using pol2 CTD-peptide substrate and [gammaP]ATP by scintillation counting method";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4106169";"CDK12/Cyclin K";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4765462";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"40.0"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"8, STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"21.95";"0.40";"4.75";"8.33";"0";"CHEMBL2424066";"Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from dog Grp94 after 24 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Canis lupus familiaris";"None";"None";"None";"None";"";"";"";"CHEMBL4748";"Heat shock protein 90 beta";"Canis lupus familiaris";"SINGLE PROTEIN";"CHEMBL2417440";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"10.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"17.07";"0.32";"4.49";"7.31";"1";"CHEMBL4386150";"Inhibition of recombinant human N-terminal GST-His6-fused CDK7 (M1 to F346 residues)/N-terminal His-tagged cyclin H (M1 to L323 residues)/N-terminal His6-tagged MAT1 (M1 to S306 residues) expressed in baculovirus infected Sf9 insect cells using (YSPTSPS)2KK as substrate measured in presence of [gamma-33P]ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3038473";"CDK7/Cyclin H/MNAT1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"0.17"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"39";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1160.0";"nM";"5.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5226853";"Anticancer activity against human HCT-116 cells assessed as reduction in cell viability incubated for 24 hrs by Cell Titer-Glo assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL394";"HCT-116";"Homo sapiens";"CELL-LINE";"CHEMBL5226288";"1";"Scientific Literature";"Eur J Med Chem";"2021";"CHEMBL3308372";"TIME = 24.0 hr";"";"";"1.16"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380105";"Cytotoxicity against human T47D cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T47D";"None";"";"";"";"CHEMBL614361";"T47D";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307606";"";"";"";"0.01"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880500";"Growth inhibition of human SW1463 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW1463";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308788";"";"";"";"0.004"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880521";"Growth inhibition of human RKO cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RKO";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307731";"";"";"";"0.005"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"18.01";"0.34";"4.86";"7.71";"1";"CHEMBL4386146";"Inhibition of His-tagged CDK1/Cyclin-B1 (unknown origin) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate measured in presence of [gamma-33P]ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1907602";"Cyclin-dependent kinase 1/cyclin B1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"0.072"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"Tafamidis";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"1620.0";"nM";"5.79";"";"";"UO_0000065";"18.79";"0.40";"1.29";"9.14";"0";"CHEMBL3871573";"Inhibition of TTR V30M mutant (unknown origin) assessed as inhibition of acid-mediated amyloidogenesis by measuring fibril formation preincubated with enzyme followed by amyloidogenesis stimulation by adjusting pH to 4.4 measured after 72 hrs relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"P02766";"V50M";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3871272";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"1.62"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4386172";"Antiproliferative activity against human Z138 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Z-138";"None";"";"";"";"CHEMBL4483276";"Z-138";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4483125";"";"";"";""
"CHEMBL2103870";"LUMACAFTOR";"4.0";"452.41";"0";"4.75";"286";"Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614956";"Inhibition of CYP2C8 (unknown origin) assessed as reduction in amodiaquine N-deethylation";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3721";"Cytochrome P450 2C8";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613261";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"12.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"14.21";"0.32";"4.80";"8.16";"0";"CHEMBL5446191";"Affinity Biochemical interaction: (ELISA (Raf-MEK-ERK cascade kinase assay, activated with c-Raf, 10 uM ATP)) EUB0000124b MAP2K1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Inhibitor | Protein family: Protein Kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5446079";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Biochemical Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"1.8"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"1";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.38";"0.27";"4.68";"4.16";"0";"CHEMBL2350855";"Inhibition of human recombinant truncated SYK (360 to 365 amino acid residues) using N-terminally biotinylated EPEGDYEEVLE peptide as substrate assessed as inhibition of [33P]-ATP incorporation incubated for 10 mins prior to substrate addition measured after 15 mins by scintillation counting";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2599";"Tyrosine-protein kinase SYK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346624";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"17.0"
"CHEMBL2103772";"RACECADOTRIL";"4.0";"385.49";"0";"2.98";"COVC-0141074610";"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103772";"RACECADOTRIL";"4.0";"385.49";"0";"2.98";"COVC-0141074610";"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'<'";"5.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380100";"Cytotoxicity against human MDA-MB-436 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-436";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL4295382";"";"";"";"0.005"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'<'";"5.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380103";"Cytotoxicity against human MDA-MB-231 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL400";"MDA-MB-231";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307960";"";"";"";"0.005"
"CHEMBL2103824";"ARHALOFENATE";"2.0";"415.80";"0";"4.16";"COVC-3894562307";"CC(=O)NCCOC(=O)[C@H](Oc1cccc(C(F)(F)F)c1)c1ccc(Cl)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909213";"DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL226";"Adenosine A1 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";"";"";"";""
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"8, STA-9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"22.78";"0.42";"5.05";"8.64";"0";"CHEMBL2424068";"Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from HSP90alpha (unknown origin) after 24 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3880";"Heat shock protein HSP 90-alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417440";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"5.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"37000.0";"nM";"4.43";"";"";"UO_0000065";"11.18";"0.21";"2.15";"4.78";"0";"CHEMBL3877182";"Inhibition of N-terminal 6His-tagged human BRDT bromodomain 1 (21 to 137 residues) expressed in Escherichia coli BL21 (DE3) using biotinylated histone H4 peptide (1 to 21 residues) containing KAc (K5/8/12/16Ac) as substrate by Alpha screen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1795185";"Bromodomain testis-specific protein";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875233";"1";"Scientific Literature";"Nat Rev Drug Discov";"2017";"None";"";"";"";"37.0"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"31; ARRY-334543, ASLAN001";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"17.98";"0.36";"3.15";"8.98";"0";"CHEMBL4342878";"Inhibition of HER4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3009";"Receptor protein-tyrosine kinase erbB-4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342409";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"4.0"
"CHEMBL2103872";"CEFTOLOZANE";"4.0";"666.70";"3";"-3.90";"CXA-101, FR-264205";"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1";"IC50";"'='";"1.36";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1658201";"Inhibition of Pseudomonas aeruginosa PAO1 PBP2 by SDS-PAGE";"B";"BAO_0000019";"assay format";"Pseudomonas aeruginosa PAO1";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1649308";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"None";"";"";"";"1.36"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'<'";"5.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380107";"Cytotoxicity against human A673 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A673";"None";"";"";"";"CHEMBL614517";"A673";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307384";"";"";"";"0.005"
"CHEMBL2103855";"TELOTRISTAT";"4.0";"546.94";"1";"4.51";"LP778902; 7.2";"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1";"IC50";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"11.18";"0.22";"1.60";"4.30";"0";"CHEMBL5141806";"Inhibition of N-terminal MBP-tagged full length human TPH1 assessed as reduction in 5-HTP formation incubated for 5 to 10 mins by fluorescence microplate reader analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5689";"Tryptophan 5-hydroxylase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137079";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Time_Lower = 5.0 min | Time_Upper = 10.0 min";"INHIBITOR";"";"0.77"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.94";"0.41";"6.42";"9.39";"1";"CHEMBL4386142";"Inhibition of His-tagged CDK2/Cyclin-E1 (unknown origin) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate measured in presence of [gamma-33P]ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1907605";"Cyclin-dependent kinase 2/cyclin E1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"0.002"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909104";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL1833";"Serotonin 2b (5-HT2b) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"'='";"90.7";"nM";"7.04";"";"";"UO_0000065";"22.54";"0.42";"3.16";"18.88";"0";"CHEMBL1909109";"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL228";"Serotonin transporter";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";"0.0907"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"COVC-3894205924";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"27";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3862056";"Cytotoxicity against human U2OS cells assessed as growth inhibition after 96 hrs by SRB assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2OS";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3861941";"1";"Scientific Literature";"Medchemcomm";"2016";"CHEMBL3307757";"";"";"";"6.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"168.0";"nM";"6.78";"";"";"UO_0000065";"17.05";"0.32";"4.35";"6.51";"0";"CHEMBL4771397";"Inhibition of human HDAC9 expressed in baculovirus infected sf9 cells using (Boc-Lys(trifluoroacetyl)-AMC) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4145";"Histone deacetylase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"168.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"8";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'<'";"3.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5109321";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107985";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.003"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"11.91";"0.22";"2.44";"5.10";"0";"CHEMBL3877181";"Inhibition of N-terminal 6His-tagged human BRD4 bromodomain 1 (44 to 168 residues) expressed in Escherichia coli BL21 (DE3) using biotinylated histone H4 peptide (1 to 21 residues) containing KAc (K5/8/12/16Ac) as substrate by Alpha screen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1163125";"Bromodomain-containing protein 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875233";"1";"Scientific Literature";"Nat Rev Drug Discov";"2017";"None";"";"";"";"19.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL3877185";"Inhibition of CDK5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875233";"1";"Scientific Literature";"Nat Rev Drug Discov";"2017";"None";"";"";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386166";"Antiproliferative activity against human HBL2 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.013"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386162";"Antiproliferative activity against human OCI-LY7 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"OCI-Ly7";"None";"";"";"";"CHEMBL4523564";"OCI-Ly7";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4523533";"";"";"";"0.002"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386175";"Antiproliferative activity against human K562 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"K562";"None";"";"";"";"CHEMBL385";"K562";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308378";"";"";"";"0.011"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"4; ARRY-334543";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.63";"0.37";"3.45";"9.30";"0";"CHEMBL3870718";"Inhibition of HER2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1824";"Receptor protein-tyrosine kinase erbB-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3870325";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";"";"2.0"
"CHEMBL2103873";"MACITENTAN";"4.0";"588.28";"1";"3.57";"43";"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"14.40";"0.36";"4.90";"6.60";"0";"CHEMBL4426325";"Antagonist activity at human ETA receptor expressed in CHO cells in presence of ET1";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL252";"Endothelin receptor ET-A";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425117";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308072";"";"";"";"3.4"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880490";"Growth inhibition of human EFM19 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"EFM-19";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308502";"";"";"";"1.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880493";"Growth inhibition of human NCI-H508 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H508";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL4632323";"";"";"";"0.023"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386173";"Antiproliferative activity against human Ramos cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL614629";"Ramos";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";"";"0.015"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386180";"Antiproliferative activity against human HeLa cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HeLa";"None";"";"";"";"CHEMBL399";"HeLa";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308376";"";"";"";"0.013"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909097";"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)";"B";"BAO_0000221";"tissue-based format";"Sus scrofa";"CHEMBL3638187";"Heart";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909102";"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3638188";"Brain";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"174.0";"nM";"6.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445911";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line HCT-15, K-Ras mutation)) EUB0000124b MAP2K2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-15";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307945";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"174.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"COVC-0136487877";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909156";"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL231";"Histamine H1 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909173";"DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL1821";"Muscarinic acetylcholine receptor M4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909116";"DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"Platelet";"None";"";"";"";"CHEMBL1835";"Thromboxane-A synthase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3833781";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909119";"DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HT-29";"Membrane";"";"";"";"CHEMBL5144";"Vasoactive intestinal polypeptide receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307768";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"'='";"113.0";"nM";"6.95";"";"";"UO_0000065";"22.23";"0.41";"3.07";"18.62";"0";"CHEMBL1909115";"DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)";"B";"BAO_0000249";"cell membrane format";"Escherichia coli";"None";"None";"None";"Membrane";"";"";"";"CHEMBL3072";"Androgen Receptor";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";"0.113"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909142";"DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL219";"Dopamine D4 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909152";"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3638188";"Brain";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909153";"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3559724";"Cerebral cortex";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909101";"DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon))";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"T47D";"Membrane";"";"";"";"CHEMBL1832";"Calcitonin receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307606";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909171";"DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL211";"Muscarinic acetylcholine receptor M2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"11";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"20.76";"0.42";"5.55";"7.70";"1";"CHEMBL5245507";"Inhibition of recombinant human JAK3 (781 to 1124 residues)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2148";"Tyrosine-protein kinase JAK3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"99.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"13";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4009226";"Inhibition of recombinant human LTA4H aminopeptidase activity expressed in Escherichia coli BL21 (DE3) pLysS assessed as formation of p-NA from Ala-p-NA preincubated for 10 mins followed by substrate addition measured after 10 mins";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4618";"Leukotriene A4 hydrolase";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007425";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4830395";"Growth inhibition of human MV4-11 cells incubated after 72 hrs by CTG- luminescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MV4-11";"None";"";"";"";"CHEMBL613835";"MV4-11";"Homo sapiens";"CELL-LINE";"CHEMBL4828743";"1";"Scientific Literature";"J Med Chem";"2021";"CHEMBL3308063";"TIME = 72.0 hr";"";"";""
"CHEMBL2103872";"CEFTOLOZANE";"4.0";"666.70";"3";"-3.90";"CXA-101, FR-264205";"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1";"IC50";"'='";"0.64";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1658200";"Inhibition of Pseudomonas aeruginosa PAO1 PBP1c by SDS-PAGE";"B";"BAO_0000019";"assay format";"Pseudomonas aeruginosa PAO1";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1649308";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"None";"";"";"";"0.64"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"Ganetespib";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'<'";"15.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5144544";"Cytotoxicity against human HaCaT cells assessed as inhibition of cell growth";"T";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HaCaT";"None";"";"";"";"CHEMBL614392";"HaCaT";"Homo sapiens";"CELL-LINE";"CHEMBL5143528";"1";"Scientific Literature";"Eur J Med Chem";"2022";"CHEMBL3308509";"";"";"";"0.015"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"Ganetespib";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5144553";"Inhibition of fungal HSP90 incubated for 6 hrs in presence of FITC-Geldanamycin by fluorescence polarization analysis";"B";"BAO_0000019";"assay format";"Fungi";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5143528";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 6.0 hr";"INHIBITOR";"";"0.66"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909181";"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"HEK293";"Membrane";"";"";"";"CHEMBL237";"Kappa opioid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307715";"";"";"";""
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445903";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line HCT-116, K-Ras mutation)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3308372";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"5.7"
"CHEMBL1203370";"";"None";"527.10";"1";"6.24";"33";"Cl.Fc1ccc(C(OCCN2CCC3CCC(C2)N3CCCc2ccccc2)c2ccc(F)cc2)cc1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL663153";"Inhibition of [3H]DA reuptake in rat caudate homogenate.";"F";"BAO_0000221";"tissue-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL338";"Dopamine transporter";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1133553";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";"";"47.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5343378";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338803";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5353928";"Inhibition of FGFR (unknown origin) by FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2095217";"Fibroblast growth factor receptor";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5353931";"Inhibition of BRAF (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5145";"Serine/threonine-protein kinase B-raf";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5352421";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"";"";""
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"10";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.14";"0.32";"4.76";"8.12";"0";"CHEMBL5131972";"Inhibition of MEK 1/2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2111289";"Dual specificity mitogen-activated protein kinase kinase; MEK1/2";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL5131376";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"2.0"
"CHEMBL2103870";"LUMACAFTOR";"4.0";"452.41";"0";"4.75";"286";"Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1";"IC50";"'='";"32000.0";"nM";"4.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614957";"Inhibition of CYP2C9 (unknown origin) assessed as reduction in diclofenac 4-hydroxylation";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3397";"Cytochrome P450 2C9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613261";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"32.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"11; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"0";"CHEMBL3856486";"Inhibition of recombinant CDK1/cyclin B (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated histone H1 as substrate after 1 hr by gamma32P-ATP based liquid scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1907602";"Cyclin-dependent kinase 1/cyclin B1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3856187";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308860";"";"";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"178.0";"nM";"6.75";"";"";"UO_0000065";"17.02";"0.32";"4.47";"7.29";"0";"CHEMBL3777660";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774312";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"0.178"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"17.39";"0.32";"4.62";"7.44";"0";"CHEMBL3776183";"Inhibition of CDK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL331";"Cyclin-dependent kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774312";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"0.127"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909090";"DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"Sf9";"Membrane";"";"";"";"CHEMBL1916";"Alpha-2c adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308860";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4841249";"Inhibition of CDK2 (unknown origin) expressed in Sf9 insect cells using biotinylated peptide derived Histone H1 as substrate incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840335";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386156";"Antiproliferative activity against human RIVA cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.031"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"2; MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4220925";"Cytotoxicity against mouse L1210 cells after 2 days by cell titer 96 aqueous one solution based assay";"F";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"L1210";"None";"";"";"";"CHEMBL386";"L1210";"Mus musculus";"CELL-LINE";"CHEMBL4219075";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"CHEMBL3308391";"";"";"";"2.1"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909099";"DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin)";"B";"BAO_0000019";"assay format";"Bacillus cereus";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909155";"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3638246";"Spinal cord";"None";"Membrane";"";"";"";"CHEMBL3392921";"Glycine receptor";"Rattus norvegicus";"PROTEIN COMPLEX GROUP";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"51";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL5131984";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131376";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"3.0"
"CHEMBL2103831";"NAPROXCINOD";"3.0";"347.37";"0";"3.48";"AZD3582";"COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1";"IC50";"'='";"467.74";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3107538";"Ex vivo vasorelaxant activity in Wistar rat endothelium thoracic aortic ring assessed as reduction of KCl-induced contraction";"F";"BAO_0000221";"tissue-based format";"Rattus norvegicus";"CHEMBL3638186";"Aorta";"None";"None";"";"";"";"CHEMBL2367449";"Thoracic aorta";"Rattus norvegicus";"TISSUE";"CHEMBL3102735";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"6.33"
"CHEMBL1203370";"";"None";"527.10";"1";"6.24";"33";"Cl.Fc1ccc(C(OCCN2CCC3CCC(C2)N3CCCc2ccccc2)c2ccc(F)cc2)cc1";"IC50";"'='";"843.0";"nM";"6.07";"";"";"UO_0000065";"12.38";"0.23";"-0.17";"38.66";"0";"CHEMBL619186";"Binding affinity for rat 5-hydroxytryptamine transporter.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL313";"Serotonin transporter";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1133553";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";"";"843.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880515";"Growth inhibition of human A427 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A-427";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307775";"";"";"";"0.022"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"4";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5033189";"Displacement of [3H]-all trans retinol from human urine biotinylated RBP4 incubated for 16 hrs measured by Scintillation Proximity Assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Urine";"None";"None";"";"";"";"CHEMBL3100";"Plasma retinol-binding protein";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5032506";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"";"";"30.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL4187421";"Inhibition of N-terminal GST-HIS6 fusion protein tagged human full length CDK9 (M1 to F372 residues)/N-terminal GST-HIS6 fusion protein tagged human Cyclin-T1 (M1 to K726 residues) expressed in Sf9 cells at 10 uM using TAMRA-Rbtide substrate and ATP incubated for 1 hr by fluorescent polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2111389";"CDK9/cyclin T1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4184207";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";"";"4.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"COVC-3359037049";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880495";"Growth inhibition of human T84 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T84";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307275";"";"";"";"0.061"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880514";"Growth inhibition of human SW900 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW900";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308819";"";"";"";"0.127"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880532";"Growth inhibition of human SW480 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW480";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307758";"";"";"";"0.026"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880539";"Growth inhibition of human Calu6 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Calu-6";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307639";"";"";"";"0.003"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"Ganetespib";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4255616";"Cytotoxicity against human CHP100 cells assessed as reduction in cell viability after 24 hrs by resazurin dye based Alamar blue assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4251686";"1";"Scientific Literature";"J Nat Prod";"2018";"None";"";"";"";""
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"16.18";"0.30";"4.01";"6.18";"0";"CHEMBL4771393";"Inhibition of human HDAC8 expressed in baculovirus infected sf9 cells using p53 residues 379-382 (RHKAcKAc) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3192";"Histone deacetylase 8";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"370.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"18.33";"0.34";"4.86";"7.00";"0";"CHEMBL4771399";"Inhibition of HDAC10 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5103";"Histone deacetylase 10";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"52.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"1";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4686981";"Antiproliferative activity against human A549 cells harboring KRAS G12S mutant assessed as inhibition of cell viability after 96 hrs by Celltiter-Glo assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL4680253";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3307651";"TIME = 96.0 hr";"";"";"0.46"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"12";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL4701383";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699469";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"3.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"1";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4686979";"Antiproliferative activity against human MDA-MB-231 cells harboring KRAS G13D/BRAF G464V mutant assessed as inhibition of cell viability after 96 hrs by Celltiter-Glo assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL400";"MDA-MB-231";"Homo sapiens";"CELL-LINE";"CHEMBL4680253";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3307960";"TIME = 96.0 hr";"";"";"0.018000000000000002"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909207";"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)";"B";"BAO_0000357";"single protein format";"Escherichia coli";"None";"None";"None";"None";"";"";"";"CHEMBL3243";"Leukocyte common antigen";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4830407";"Inhibition of human ALK2 using casein as substrate incubated for 2 hrs by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5903";"Activin receptor type-1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4828743";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"3; SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL4348722";"Inhibition of recombinant CDK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated peptide as substrate after 1 hr in presence of [33P]ATP by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346699";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"3; SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4348723";"Inhibition of recombinant CDK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated peptide as substrate after 1 hr in presence of [33P]ATP by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346699";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"3; SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4348724";"Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated peptide as substrate after 1 hr in presence of [33P]ATP by TopCount scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346699";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";"";"1.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880510";"Growth inhibition of human MV522 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MV522";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"None";"";"";"";"0.002"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880543";"Growth inhibition of human HOP62 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HOP-62";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307671";"";"";"";"0.05"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880541";"Growth inhibition of human NCI-H1155 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H1155";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308312";"";"";"";"0.01"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880508";"Growth inhibition of human NCI-H23 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H23";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307750";"";"";"";"0.029"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"0";"CHEMBL4739334";"Inhibition of CDK2/cyclin E (unknown origin) using peptide substrate in presence of [gamma33P]ATP by image analyser";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907605";"Cyclin-dependent kinase 2/cyclin E1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4732259";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.004"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"10; SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5131645";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386169";"Antiproliferative activity against human Mino cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.011"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386181";"Antiproliferative activity against human HCT116 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL394";"HCT-116";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308372";"";"";"";"0.007"
"CHEMBL2103828";"ELINOGREL";"2.0";"523.96";"1";"3.09";"63";"CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5126994";"Antiplatelet activity in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Platelet";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5126507";"1";"Scientific Literature";"Eur J Med Chem";"2022";"CHEMBL4295368";"";"";"";"10.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"MK7965; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4346789";"Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of cyclin by [33P]-ATP-based liquid scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346652";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"MK7965; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL4346787";"Inhibition of recombinant CDK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of cyclin by [33P]-ATP-based liquid scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346652";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"8";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"18.60";"0.35";"5.10";"7.96";"0";"CHEMBL5109327";"Inhibition of CDK7 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3055";"Cyclin-dependent kinase 7";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107985";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.042"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909110";"DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"Jurkat";"Membrane";"";"";"";"CHEMBL287";"Sigma opioid receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307526";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909111";"DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil)";"B";"BAO_0000249";"cell membrane format";"Rattus norvegicus";"CHEMBL3638188";"Brain";"None";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909206";"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Insect cells";"None";"";"";"";"CHEMBL258";"Tyrosine-protein kinase LCK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909113";"DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL249";"Neurokinin 1 receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909200";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)";"B";"BAO_0000357";"single protein format";"Escherichia coli";"None";"None";"None";"None";"";"";"";"CHEMBL4040";"MAP kinase ERK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"10; SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5253653";"Inhibition of CDK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252533";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL1203860";"";"None";"503.46";"1";"5.87";"63";"Cl.Cl.Fc1ccc(C2CC(N3CCN(C/C=C/c4ccccc4)CC3)c3cc(F)ccc32)cc1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL670185";"Effect on synaptosomal uptake inhibition of Dopamine transporter";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL338";"Dopamine transporter";"Rattus norvegicus";"SINGLE PROTEIN";"CHEMBL1122477";"1";"Scientific Literature";"J Med Chem";"1983";"None";"";"";"";"340.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386178";"Antiproliferative activity against human RPMI8226 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RPMI-8226";"None";"";"";"";"CHEMBL614882";"RPMI-8226";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307732";"";"";"";"0.009"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386164";"Antiproliferative activity against human SUDHL4 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SUD4";"None";"";"";"";"CHEMBL613711";"SUD4";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308053";"";"";"";"0.01"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.71";"nM";"9.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5152796";"Cytotoxicity against human LNCaP cells assessed as reduction in cell viability incubated for 72 hrs in presence of TTR by CellTiter-96 assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LNCaP";"None";"";"";"";"CHEMBL612518";"LNCaP";"Homo sapiens";"CELL-LINE";"CHEMBL5150030";"1";"Scientific Literature";"J Med Chem";"2022";"CHEMBL3307965";"TIME = 72.0 hr";"";"";"0.71"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"18.01";"0.34";"4.86";"7.71";"0";"CHEMBL3767305";"Inhibition of CDK1/Cyclin B (unknown origin) expressed in baculoviral infected insect Sf9 cells using histone H1 as substrate in presence of [gamma-33P]ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1907602";"Cyclin-dependent kinase 1/cyclin B1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3763042";"1";"Scientific Literature";"Eur J Med Chem";"2016";"CHEMBL3308860";"";"";"";"0.072"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"18.53";"0.35";"5.07";"7.93";"0";"CHEMBL3767308";"Inhibition of CDK5/p35NCK (unknown origin) using histone H1 as substrate in presence of [gamma-33P]ATP";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907600";"Cyclin-dependent kinase 5/CDK5 activator 1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3763042";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"0.045"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"17.07";"0.32";"4.49";"7.31";"0";"CHEMBL3767462";"Inhibition of CDK7/Cyclin H/MAT1 (unknown origin) using (YSPTSPS)2KK peptide as substrate in presence of [gamma-33P]ATP";"B";"BAO_0000223";"protein complex format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3038473";"CDK7/Cyclin H/MNAT1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3763042";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"0.17"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880529";"Growth inhibition of human COLO205 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"COLO 205";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308348";"";"";"";"0.001"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880537";"Growth inhibition of human NCI-H1792 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H1792";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308816";"";"";"";"0.035"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"COVC-3357334973";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4830411";"Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate incubated for 2 hrs by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL299";"Protein kinase C alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4828743";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"";"";""
"CHEMBL2103847";"TOSEDOSTAT";"2.0";"406.48";"0";"1.86";"CHR 2797";"CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"16.54";"0.32";"4.86";"5.38";"0";"CHEMBL4407171";"Inhibition of MMP2 (unknown origin) using QF-24 as substrate preincubated for 1 hr followed by substrate addition and measured at 1 min interval for 1 hr by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL333";"Matrix metalloproteinase-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406801";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.19"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"19.73";"0.37";"5.54";"8.45";"0";"CHEMBL4386151";"Inhibition of recombinant human N-terminal GST-His6-fused CDK9 (M1 to F372 residues)/N-terminal His6-tagged cyclin T1 (M1 to K726 residues) expressed in baculovirus infected Sf9 insect cells using (YSPTSPS)2KK as substrate measured in presence of [gamma-33P]ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2111389";"CDK9/cyclin T1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"0.015"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386182";"Antiproliferative activity against human G361 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"G-361";"None";"";"";"";"CHEMBL614036";"G-361";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307514";"";"";"";"0.016"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103873";"MACITENTAN";"4.0";"588.28";"1";"3.57";"COVC-2833803927";"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103835";"";"None";"717.99";"1";"3.53";"2; MMAE";"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C";"IC50";"'='";"0.66";"nM";"9.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4220923";"Cytotoxicity against human SKOV3 cells after 2 days by cell titer 96 aqueous one solution based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-OV-3";"None";"";"";"";"CHEMBL614925";"SK-OV-3";"Homo sapiens";"CELL-LINE";"CHEMBL4219075";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"CHEMBL3307746";"";"";"";"0.66"
"CHEMBL2103775";"ALACEPRIL";"2.0";"406.50";"0";"1.71";"COVC-2835348541";"CC(=O)SC[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103873";"MACITENTAN";"4.0";"588.28";"1";"3.57";"17, Macitentan, ACT-064992";"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"15.81";"0.40";"5.73";"7.25";"0";"CHEMBL2166382";"Displacement of [I125]ET1 from recombinant ETA receptor expressed in CHO cells after 2 hrs by TopCount analysis";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL252";"Endothelin receptor ET-A";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163289";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";"";"0.5"
"CHEMBL2103772";"RACECADOTRIL";"4.0";"385.49";"0";"2.98";"Racecadotril";"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1";"IC50";"'='";"20300.0";"nM";"4.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4028921";"Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL6020";"Bile salt export pump";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028801";"1";"Scientific Literature";"Toxicol Sci";"2013";"None";"";"";"";"20.3"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"3";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"50.45";"nM";"7.30";"";"";"UO_0000065";"20.02";"0.37";"4.05";"7.60";"0";"CHEMBL4614279";"Inhibition of recombinant HSP90alpha (unknown origin) incubated for 24 hrs in presence of 1-FITC3 probe by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3880";"Heat shock protein HSP 90-alpha";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613233";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"50.45"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909162";"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"U-937";"Membrane";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308006";"";"";"";""
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"3";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"37.7";"nM";"7.42";"";"";"UO_0000065";"20.37";"0.38";"4.17";"7.73";"0";"CHEMBL4614281";"Inhibition of GRP94 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1075323";"Endoplasmin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613233";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"37.7"
"CHEMBL2103822";"TASIMELTEON";"4.0";"245.32";"0";"2.25";"COVC-0673206506";"CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"COVC-3359037049";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL5224412";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223102";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"16; SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5123367";"Inhibition of CDK2/Cyclin E (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5120846";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103828";"ELINOGREL";"2.0";"523.96";"1";"3.09";"2, PRT-128";"CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F";"IC50";"'='";"2810.0";"nM";"5.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2175135";"Inhibition of ADP-stimulated platelet aggregation in human platelet rich plasma by 96-well format based turbidimetric method";"F";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"Platelet";"None";"";"";"";"CHEMBL4296519";"Platelet";"";"CELL-LINE";"CHEMBL2169809";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3833781";"";"";"";"2.81"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'<'";"5.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2380106";"Cytotoxicity against human SK-ES-1 cells after 72 hrs by resazurin/resorufin-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-ES1";"None";"";"";"";"CHEMBL613970";"SK-ES1";"Homo sapiens";"CELL-LINE";"CHEMBL2375244";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3307826";"";"";"";"0.005"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"Abexinostat (PCI-24781)";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"72.19";"nM";"7.14";"";"";"UO_0000065";"17.97";"0.34";"4.72";"6.86";"0";"CHEMBL4808152";"Determination of IC50 values for inhibition of enzymatic assay of human HDAC6 with custom peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1865";"Histone deacetylase 6";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4808148";"59";"Fraunhofer Institute HDAC6 screening";"";"2021";"None";"";"";"";"0.07219"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5132026";"Antiviral activity against SARS-CoV-2 in african green monkey VeroE6 cells assessed as inhibition of viral growth";"F";"BAO_0000218";"organism-based format";"Severe acute respiratory syndrome coronavirus 2";"None";"None";"Vero E6";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL5131378";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"";"";"0.27"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"1";"CHEMBL5123370";"Inhibition of CDK9/Cyclin T (unknown origin)";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"";"";"";"CHEMBL2111389";"CDK9/cyclin T1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5120846";"1";"Scientific Literature";"J Med Chem";"2022";"CHEMBL3307588";"";"INHIBITOR";"";"4.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"EUB0000124b";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"8.5";"nM";"8.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445905";"Affinity Phenotypic Cellular interaction: (Cytotoxicity sulforhodamine B assay (growth inhibitory activity in human colorectal cancer cell line SW480, K-Ras mutation)) EUB0000124b MAP2K1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW480";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307758";"Affinity Phenotypic Cellular Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"8.5"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"COVC-0136487877";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'>'";"20000.0";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"0.00002"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880520";"Growth inhibition of human EFM19 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"EFM-19";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308502";"";"";"";"0.03"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880524";"Growth inhibition of human DLD1 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DLD-1";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307580";"";"";"";"0.093"
"CHEMBL2105695";"TELOTRISTAT ETHYL";"4.0";"574.99";"1";"4.99";"COVC-1746072585";"CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103822";"TASIMELTEON";"4.0";"245.32";"0";"2.25";"COVC-0673206506";"CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2";"IC50";"'>'";"19952.62";"nM";"";"";"No. Measurements = 1";"UO_0000065";"";"";"";"";"0";"CHEMBL4651403";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"F";"BAO_0000218";"organism-based format";"Chlorocebus sabaeus";"None";"None";"Vero C1008";"None";"";"";"";"CHEMBL4303835";"SARS-CoV-2";"Severe acute respiratory syndrome coronavirus 2";"ORGANISM";"CHEMBL4651402";"57";"IMI-CARE SARS-CoV-2 Data";"";"2021";"CHEMBL4295411";"";"";"";"4.7"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"18.09";"0.34";"4.89";"7.74";"0";"CHEMBL4386149";"Inhibition of recombinant human full-length N-terminal GST-His6 fused CDK5 (M1 to P292 residues)/N-terminal His6-tagged p25 (A104 to R307 residues) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate measured in presence of [gamma-33P]ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1907600";"Cyclin-dependent kinase 5/CDK5 activator 1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"0.067"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386160";"Antiproliferative activity against human TMD8 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TMD8";"None";"";"";"";"CHEMBL4296503";"TMD8";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4295480";"";"";"";"0.017"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"5";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5122293";"Inhibition of MEK1/2 (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5120797";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.002"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386177";"Antiproliferative activity against human THP1 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL614245";"THP-1";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307574";"";"";"";"0.007"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"6; STA9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4425234";"Inhibition of E6a/b;A20 EML4-ALK (unknown origin) expressed in human NCI-H2228 cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H2228";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4425084";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308120";"";"";"";"13.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"DIN";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5136673";"Inhibition of GST-tagged human CDK5/p25 expressed in Sf9 cells using histone H1 as substrate in presence of ATP and [gamma33-P] ATP by radioisotope filter binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5131567";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.013000000000000001"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"6; STA9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4425236";"Inhibition of E13;A20 EML4-ALK variant (unknown origin) expressed in human NCI-H3122 cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H3122";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4425084";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL4295436";"";"";"";"10.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"14.88";"0.34";"5.21";"8.55";"0";"CHEMBL4433500";"Inhibition of MEK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3587";"Dual specificity mitogen-activated protein kinase kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4433204";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"0.7"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880526";"Growth inhibition of human KM12 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KM12";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307689";"";"";"";"0.01"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880527";"Growth inhibition of human SW837 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW837";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308361";"";"";"";"0.025"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880544";"Growth inhibition of human SW900 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW900";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308819";"";"";"";"0.072"
"CHEMBL2103873";"MACITENTAN";"4.0";"588.28";"1";"3.57";"Macitentan";"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1";"IC50";"'='";"10000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4399827";"Inhibition of human recombinant NTCP expressed in CHO cells assessed as reduction in [3H]taurocholate uptake preincubated for 1 hr by radioactive scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL5287";"Bile acid transporter";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4396941";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";"";"";"";"10.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4386163";"Antiproliferative activity against human SUDHL10 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SU-DHL10";"None";"";"";"";"CHEMBL4483268";"SU-DHL10";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4483178";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386171";"Antiproliferative activity against human UPF7U cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.019"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386158";"Antiproliferative activity against human U2932 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U2932";"None";"";"";"";"CHEMBL4296507";"U2932";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4295421";"";"";"";"0.011"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909089";"DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL1942";"Alpha-2b adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"DIN";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"20.74";"0.39";"5.94";"8.88";"0";"CHEMBL5136674";"Inhibition of GST-tagged human CDK9/Cyclin T1 expressed in Sf9 cells using (YSPTSPS)2KK peptide as substrate in presence of ATP and [gamma33-P] ATP by radioisotope filter binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2111389";"CDK9/cyclin T1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5131567";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.006"
"CHEMBL2103837";"TAFAMIDIS";"4.0";"308.12";"0";"4.50";"1";"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"18.13";"0.38";"1.09";"8.82";"0";"CHEMBL4833461";"Stabilization of TTR V30M mutant (unknown origin) assessed as acid-mediated protein aggregation inhibition ratio incubated for 1 week by absorbance method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"P02766";"V50M";"CHEMBL3194";"Transthyretin";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4831538";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 168.0 hr";"STABILISER";"";"2.6"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"4; ARRY-334543";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"17.46";"0.35";"2.90";"8.72";"0";"CHEMBL3870717";"Inhibition of EGFR (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL203";"Epidermal growth factor receptor erbB1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3870325";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";"";"7.0"
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909118";"DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"HUVEC";"None";"";"";"";"CHEMBL1868";"Vascular endothelial growth factor receptor 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307501";"";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909105";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO-K1";"Membrane";"";"";"";"CHEMBL225";"Serotonin 2c (5-HT2c) receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307512";"";"";"";""
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"39";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1340.0";"nM";"5.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5226852";"Anticancer activity against human DLD-1 cells assessed as reduction in cell viability incubated for 24 hrs by Cell Titer-Glo assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DLD-1";"None";"";"";"";"CHEMBL614285";"DLD-1";"Homo sapiens";"CELL-LINE";"CHEMBL5226288";"1";"Scientific Literature";"Eur J Med Chem";"2021";"CHEMBL3307580";"TIME = 24.0 hr";"";"";"1.34"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"DIN";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"20.57";"0.38";"5.87";"8.80";"0";"CHEMBL5136675";"Inhibition of GST-tagged human CDK12/Cyclin K expressed in Sf9 cells using RBER-IRStide peptide as substrate in presence of ATP and [gamma33-P] ATP by radioisotope filter binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4106169";"CDK12/Cyclin K";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5131567";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.006999999999999999"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"10; SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5131644";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"0.74";"nM";"9.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379933";"Antiproliferative activity against human A375 cells assessed as reduction in cell viability";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A-375";"None";"";"";"";"CHEMBL613859";"A-375";"Homo sapiens";"CELL-LINE";"CHEMBL4376845";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308077";"";"";"";"0.74"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"30";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"8.06";"0.16";"1.59";"2.51";"0";"CHEMBL5253678";"Inhibition of human recombinant BRDT";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1795185";"Bromodomain testis-specific protein";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252533";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"INHIBITOR";"";"21.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"4";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL4403342";"Inhibition of CDK5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402527";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"1.0"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"3";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"37.7";"nM";"7.42";"";"";"UO_0000065";"20.37";"0.38";"4.17";"7.73";"0";"CHEMBL4614280";"Inhibition of TRAP1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1075132";"Heat shock protein 75 kDa, mitochondrial";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613233";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"37.7"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"16; SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5123365";"Inhibition of CDK1/Cyclin B (unknown origin)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL5120846";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386159";"Antiproliferative activity against human HBL1 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.013"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib (SCH727965)";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5253663";"Inhibition of CDK5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252533";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103855";"TELOTRISTAT";"4.0";"546.94";"1";"4.51";"LP778902; 7.2";"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"11.24";"0.22";"1.64";"4.32";"0";"CHEMBL5141807";"Inhibition of N-terminal MBP-tagged full length human TPH2 assessed as reduction in 5-HTP formation incubated for 5 to 10 mins by fluorescence microplate reader analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5433";"Tryptophan 5-hydroxylase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137079";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Time_Lower = 5.0 min | Time_Upper = 10.0 min";"INHIBITOR";"";"0.71"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"1";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4686980";"Antiproliferative activity against human HCT116 cells harboring KRAS G13D mutant assessed as inhibition of cell viability after 96 hrs by Celltiter-Glo assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL394";"HCT-116";"Homo sapiens";"CELL-LINE";"CHEMBL4680253";"1";"Scientific Literature";"Eur J Med Chem";"2020";"CHEMBL3308372";"TIME = 96.0 hr";"";"";"0.019"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4386157";"Antiproliferative activity against human OCI-LY3 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"OCI-Ly3";"None";"";"";"";"CHEMBL4523565";"OCI-Ly3";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4523534";"";"";"";""
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386167";"Antiproliferative activity against human JeKo1 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"JeKo-1";"None";"";"";"";"CHEMBL4296445";"JeKo-1";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4295383";"";"";"";"0.014"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"6; STA9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"19.76";"0.36";"3.95";"7.50";"0";"CHEMBL4425230";"Inhibition of Hsp90 in human MG63 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2095165";"Heat shock protein HSP90";"Homo sapiens";"PROTEIN FAMILY";"CHEMBL4425084";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"63.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"19";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"16.74";"0.31";"4.36";"7.17";"0";"CHEMBL4668530";"Inhibition of AKR1C3 (unknown origin) expressed in human HCT116 cells incubated for 3 to 6 hrs by UHPLC analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL4681";"Aldo-keto-reductase family 1 member C3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665678";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME: 3-6";"INHIBITOR";"";"0.23"
"CHEMBL2103847";"TOSEDOSTAT";"2.0";"406.48";"0";"1.86";"3";"CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO";"IC50";"'='";"680.0";"nM";"6.17";"";"";"UO_0000065";"15.17";"0.29";"4.31";"4.94";"0";"CHEMBL4132610";"Inhibition of recombinant human C-terminal His10-tagged APN (Lys69 to Lys967 residues) using Ala-AMC as substrate measured for 30 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907";"Aminopeptidase N";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130381";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";"";"0.68"
"CHEMBL2103828";"ELINOGREL";"2.0";"523.96";"1";"3.09";"Elinogrel";"CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F";"IC50";"'<'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3802948";"Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2001";"Purinergic receptor P2Y12";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"10.0"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"20";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"18.42";"0.34";"4.90";"7.03";"0";"CHEMBL4771395";"Inhibition of human HDAC5 expressed in baculovirus infected sf9 cells using (Boc-Lys(trifluoroacetyl)-AMC) as substrate by fluorescence-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2563";"Histone deacetylase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765362";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"48.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"78";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"20.18";"0.38";"5.72";"8.64";"0";"CHEMBL5227264";"Inhibition of CDK2 (unknown origin) by western blot assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL301";"Cyclin-dependent kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5226297";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880503";"Growth inhibition of human SW1417 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SW1417";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308129";"";"";"";"0.003"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"38; GSK1120212";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"14.21";"0.32";"4.80";"8.16";"0";"CHEMBL5131620";"Non competitive inhibition of MEK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.8"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"8";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"18.41";"0.34";"5.02";"7.88";"0";"CHEMBL5109320";"Inhibition of CDK12 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3559692";"Cyclin-dependent kinase 12";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107985";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.05"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386176";"Antiproliferative activity against human CEM cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CCRF-CEM";"None";"";"";"";"CHEMBL382";"CCRF-CEM";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307641";"";"";"";"0.007"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386168";"Antiproliferative activity against human Maver1 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Maver1";"None";"";"";"";"CHEMBL4483260";"Maver1";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4482995";"";"";"";"0.017"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"Fostamatinib";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"12.58";"0.25";"4.21";"3.91";"0";"CHEMBL5128713";"Inhibition of human ABCG2 expressing membrane vesicles assessed inhibition of BCRP- mediated transport of [3H]estrone 3-sulfate for 2 mins using [3H]-estrone sulfate as substrate by radiometric scintillation analysis";"B";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"None";"Membrane vesicle";"";"";"";"CHEMBL5393";"ATP-binding cassette sub-family G member 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126555";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.03333 hr";"INHIBITOR";"";"0.05"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"8";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'<'";"3.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5109328";"Inhibition of CDK9 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107985";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.003"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"DIN";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"17.50";"0.33";"4.66";"7.49";"0";"CHEMBL5136672";"Inhibition of GST-tagged CDK2/cyclin D1 (unknown origin) expressed in Sf9 cells using RPPTLSPIPHIPR peptide as substrate in presence of ATP and [gamma33-P] ATP by radioisotope filter binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3885552";"Cyclin-dependent kinase 2/G1/S-specific cyclin-D1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5131567";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.115"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386161";"Antiproliferative activity against human OCI-Ly2 cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.011"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"17.50";"0.33";"4.66";"7.49";"0";"CHEMBL4386148";"Inhibition of recombinant human N-terminal GST-fused CDK4 (S4 to E303 residues)/cyclin D1 (Q4 to I295 residues) expressed in baculovirus infected Sf9 insect cells using RPPTLSPIPHIPR as substrate measured in presence of [gamma-33P]ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL1907601";"Cyclin-dependent kinase 4/cyclin D1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";"";"0.115"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386170";"Antiproliferative activity against human UPF1H cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.013"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4386174";"Antiproliferative activity against human Raji cells assessed as growth inhibition measured after 72 hrs by calcein AM dye-based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Raji";"None";"";"";"";"CHEMBL614628";"Raji";"Homo sapiens";"CELL-LINE";"CHEMBL4385606";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307663";"";"";"";"0.025"
"CHEMBL2103873";"MACITENTAN";"4.0";"588.28";"1";"3.57";"17, Macitentan, ACT-064992";"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1";"IC50";"'='";"391.0";"nM";"6.41";"";"";"UO_0000065";"10.89";"0.27";"2.84";"5.00";"0";"CHEMBL2166381";"Displacement of [I125]ET1 from recombinant ETB receptor expressed in CHO cells after 2 hrs by TopCount analysis";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL1785";"Endothelin receptor ET-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2163289";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3308072";"";"";"";"391.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880511";"Growth inhibition of human NCI-H1155 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H1155";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308312";"";"";"";"1.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880518";"Growth inhibition of human NCI-H727 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H727";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308393";"";"";"";"0.002"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880525";"Growth inhibition of human T84 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T84";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307275";"";"";"";"0.03"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880498";"Growth inhibition of human LS1034 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LS-1034";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308846";"";"";"";"0.005"
"CHEMBL2103863";"ABEXINOSTAT";"3.0";"397.43";"0";"2.42";"15";"CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"21.14";"0.40";"5.98";"8.07";"0";"CHEMBL4386404";"Inhibition of tubastatin-Alexa647-tracer binding to recombinant GST-tagged HDAC10 (unknown origin) measured after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5103";"Histone deacetylase 10";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385610";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"8.4"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"0";"CHEMBL4841248";"Inhibition of CDK1 (unknown origin) expressed in Sf9 insect cells using biotinylated peptide derived Histone H1 as substrate incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840335";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1.0"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"3";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"9.3";"nM";"8.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614285";"Antiproliferative activity against human PC3 cells by MTT assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PC-3";"None";"";"";"";"CHEMBL390";"PC-3";"Homo sapiens";"CELL-LINE";"CHEMBL4613233";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307570";"";"";"";"9.3"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"6; STA9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4425228";"Cytotoxicity against human NB39 cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo luminescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4425084";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"10.0"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"6; STA9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4425243";"Cytotoxicity against human A375 cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo luminescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A-375";"None";"";"";"";"CHEMBL613859";"A-375";"Homo sapiens";"CELL-LINE";"CHEMBL4425084";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308077";"";"";"";"15.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5048672";"Antiproliferative activity against human HEK293T cells assessed as cell growth inhibition incubated for 48 hrs";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-293T";"None";"";"";"";"CHEMBL3706568";"HEK-293T";"Homo sapiens";"CELL-LINE";"CHEMBL5046275";"1";"Scientific Literature";"J Med Chem";"2022";"CHEMBL3706569";"TIME = 48.0 hr";"";"";"0.023"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"11";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"20.97";"0.42";"5.63";"7.78";"0";"CHEMBL5245508";"Inhibition of recombinant human TYK2 (870 to 1187 residues)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"84.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Tram";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"38100.0";"nM";"4.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5385649";"Cytotoxicity against human Trametinib-resistant A549 cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter 96 cell proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL5380875";"1";"Scientific Literature";"J Med Chem";"2023";"CHEMBL3307651";"TIME = 72.0 hr";"";"";"38.1"
"CHEMBL2103828";"ELINOGREL";"2.0";"523.96";"1";"3.09";"63";"CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"13.93";"0.29";"4.21";"5.14";"0";"CHEMBL5126995";"Displacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2001";"Purinergic receptor P2Y12";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126507";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.3333 hr";"ANTAGONIST";"";"0.05"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"14.68";"0.33";"5.10";"8.43";"0";"CHEMBL5446192";"Affinity Biochemical interaction: (ELISA (Raf-MEK-ERK cascade kinase assay, activated with c-Raf, 10 uM ATP)) EUB0000124b MAP2K2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Inhibitor | Protein family: Protein Kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL2964";"Dual specificity mitogen-activated protein kinase kinase 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5446079";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Biochemical Source Knowledge: https://www.spandidos-publications.com/10.3892/ijo.2011.1015";"";"";"0.92"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"2; SCH727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"0";"CHEMBL4841252";"Inhibition of CDK9 (unknown origin) expressed in Sf9 insect cells using biotinylated peptide derived Histone H1 as substrate incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3116";"Cyclin-dependent kinase 9";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840335";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880548";"Growth inhibition of human NCI-H727 cells at 1:10 molar ratio of compound in presence of N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecar- boxamide incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H727";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3308393";"";"";"";"0.002"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Compound A";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"632.0";"nM";"6.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3880494";"Growth inhibition of human DLD1 cells incubated for 72 hrs by Cell-titer-Glo reagent based assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DLD-1";"None";"";"";"";"CHEMBL3879801";"NON-PROTEIN TARGET";"";"NON-MOLECULAR";"CHEMBL3880386";"38";"SureChEMBL Patent Bioactivity Data";"";"2014";"CHEMBL3307580";"";"";"";"0.632"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"8";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"19.98";"0.37";"5.64";"8.55";"0";"CHEMBL5109326";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107985";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.012"
"CHEMBL2103879";"GANETESPIB";"3.0";"364.41";"0";"3.25";"6; STA9090";"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4425229";"Inhibition of EML4-ALK variant 1 (unknown origin) expressed in BA/F3 cells assessed as decrease in cell viability after 24 hrs by CellTiter-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL612545";"Unchecked";"";"UNCHECKED";"CHEMBL4425084";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"11.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"10; SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5131615";"Inhibition of CDK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL331";"Cyclin-dependent kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"27";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.18";"0.40";"6.12";"9.07";"0";"CHEMBL3862055";"Inhibition of recombinant full-length N-terminal GST-tagged human CDK9 (1 to 372 residues)/full-length His6-tagged human cyclin T1 (1 to 726 residues) expressed in baculovirus expression system using 5'FAM-RRRFRPASPLRGPPK-COOH as substrate after 30 mins by microfluidic assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2111389";"CDK9/cyclin T1";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL3861941";"1";"Scientific Literature";"Medchemcomm";"2016";"None";"";"";"";"4.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"10; SCH 727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5131649";"Inhibition of Cdk5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"DIN";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"19.36";"0.36";"5.40";"8.29";"0";"CHEMBL5136676";"Inhibition of GST-tagged human CDK13/Cyclin K expressed in Sf9 cells using RBER-IRStide peptide as substrate in presence of ATP and [gamma33-P] ATP by radioisotope filter binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL4296067";"Cyclin-dependent kinase 13/Cyclin-K";"Homo sapiens";"PROTEIN COMPLEX";"CHEMBL5131567";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.021"
"CHEMBL2103873";"MACITENTAN";"4.0";"588.28";"1";"3.57";"43";"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"15.81";"0.40";"5.73";"7.25";"1";"CHEMBL4426323";"Displacement of [125I]-ET-1 from human ETA receptor expressed in CHO cell membranes after 2 hrs by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL252";"Endothelin receptor ET-A";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425117";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308072";"";"";"";"0.5"
"CHEMBL2103873";"MACITENTAN";"4.0";"588.28";"1";"3.57";"43";"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1";"IC50";"'='";"987.0";"nM";"6.01";"";"";"UO_0000065";"10.21";"0.26";"2.44";"4.68";"0";"CHEMBL4426320";"Antagonist activity at human ETB receptor expressed in CHO cells in presence of ET1";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL1785";"Endothelin receptor ET-B";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425117";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308072";"";"";"";"987.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"10; SCH-727965";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL5253656";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252533";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"INHIBITOR";"";"3.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"1";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.50";"0.40";"6.24";"9.20";"1";"CHEMBL5343377";"Inhibition of CDK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL308";"Cyclin-dependent kinase 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338803";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"3.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Tram";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"IC50";"'='";"296.0";"nM";"6.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5385648";"Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter 96 cell proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"A549";"None";"";"";"";"CHEMBL392";"A549";"Homo sapiens";"CELL-LINE";"CHEMBL5380875";"1";"Scientific Literature";"J Med Chem";"2023";"CHEMBL3307651";"TIME = 72.0 hr";"";"";"296.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"1";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.42";"6.72";"9.72";"1";"CHEMBL5343376";"Inhibition of CDK5 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4036";"Cyclin-dependent kinase 5";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338803";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
